WEBVTT - From the Vault - Hepatitis B: Hepatiti, Take 2 (Ep 89)

0:00:02.279 --> 0:00:06.360
<v Speaker 1>My name is su Wang. I am a physician. I'm

0:00:06.360 --> 0:00:10.280
<v Speaker 1>an MD MPH. I'm the medical director for the Center

0:00:10.320 --> 0:00:14.280
<v Speaker 1>for Asian Health and Viral Hepatitis Programs at the Cooperman

0:00:14.640 --> 0:00:19.799
<v Speaker 1>Barnabas Medical Center in New Jersey. And I'm also just

0:00:19.880 --> 0:00:24.000
<v Speaker 1>coming off a two year presidency for the World Hepatitis Alliance,

0:00:24.040 --> 0:00:29.360
<v Speaker 1>which is a nonprofit organization that represents patients living with

0:00:29.440 --> 0:00:32.880
<v Speaker 1>viral hepatitis. And our goal is to harness the power

0:00:32.920 --> 0:00:37.279
<v Speaker 1>of people living with viral hepatitis to achieve global elimination

0:00:37.360 --> 0:00:42.520
<v Speaker 1>of viral hepatitis. I was diagnosed with hepatitis B in college.

0:00:43.159 --> 0:00:46.040
<v Speaker 1>In my first year of college, I went to donate blood,

0:00:46.200 --> 0:00:51.120
<v Speaker 1>right to do a good thing, donate blood, and shortly

0:00:51.159 --> 0:00:54.200
<v Speaker 1>after I got a big, fat envelope sent to my

0:00:54.320 --> 0:00:58.960
<v Speaker 1>dorm and it said, don't be worried. You don't have HIV,

0:00:59.440 --> 0:01:03.120
<v Speaker 1>but you do have hepatitis B. And I was a

0:01:03.120 --> 0:01:05.919
<v Speaker 1>pre med student, but honestly I didn't know anything about

0:01:05.920 --> 0:01:09.800
<v Speaker 1>hep BEE. I called my sister, confided in her about

0:01:09.800 --> 0:01:12.240
<v Speaker 1>this new diagnosis, and she said, oh, didn't you know

0:01:12.480 --> 0:01:15.400
<v Speaker 1>Mom also has hep BE. And then I just I

0:01:15.440 --> 0:01:17.639
<v Speaker 1>just remember thinking, Oh, who do I need to tell

0:01:18.440 --> 0:01:20.840
<v Speaker 1>and when I went back home, I did go see

0:01:20.840 --> 0:01:23.920
<v Speaker 1>a doctor and talked to her about it, and I

0:01:23.959 --> 0:01:26.200
<v Speaker 1>think she did blood work and basically said I was

0:01:26.200 --> 0:01:28.319
<v Speaker 1>a carrier and there was nothing to worry about. So

0:01:28.600 --> 0:01:31.440
<v Speaker 1>I honestly pushed it to the back burner. Didn't want

0:01:31.440 --> 0:01:34.080
<v Speaker 1>to think about it, so it didn't come up again

0:01:34.160 --> 0:01:38.240
<v Speaker 1>until med school. I filled in all my med school

0:01:38.520 --> 0:01:41.640
<v Speaker 1>forms and a lot of our employment forms and our

0:01:41.720 --> 0:01:45.039
<v Speaker 1>screenings for working at a hospital. You do have to

0:01:45.400 --> 0:01:49.640
<v Speaker 1>indicate you know what your heppy vaccination and statuses. And

0:01:49.840 --> 0:01:53.440
<v Speaker 1>I had indicated that I was a carrier and didn't

0:01:53.760 --> 0:01:55.560
<v Speaker 1>hear anything about it. I didn't think anything of it.

0:01:55.600 --> 0:01:56.880
<v Speaker 2>And it's not untill now.

0:01:56.920 --> 0:01:59.840
<v Speaker 1>That I've heard numerous people who are in med school

0:02:00.000 --> 0:02:02.560
<v Speaker 1>found out to have happy and actually they lose their

0:02:02.560 --> 0:02:05.760
<v Speaker 1>acceptances to med school or they faced quite a bit

0:02:05.800 --> 0:02:08.480
<v Speaker 1>of what I would consider discrimination over their status.

0:02:09.040 --> 0:02:09.160
<v Speaker 3>Uh.

0:02:09.320 --> 0:02:11.760
<v Speaker 1>And it's happened to residents, it's happened to nurses, it's

0:02:11.760 --> 0:02:15.200
<v Speaker 1>happened to deal students. So it is an issue of

0:02:15.320 --> 0:02:18.440
<v Speaker 1>stigma and discrimination. But I was fortunate it didn't happen

0:02:18.440 --> 0:02:20.560
<v Speaker 1>to me, and kind of was in the back of

0:02:20.560 --> 0:02:22.600
<v Speaker 1>my mind, and I remember kind of when we learned

0:02:22.600 --> 0:02:25.200
<v Speaker 1>about hepatitis is kind of listening a little bit more attentively.

0:02:26.080 --> 0:02:29.880
<v Speaker 1>And when I got to residency after med school, I

0:02:29.880 --> 0:02:32.360
<v Speaker 1>became really good friends with somebody. A friend of mine

0:02:32.400 --> 0:02:36.400
<v Speaker 1>went into infectious disease, and I had confided in her

0:02:36.440 --> 0:02:39.520
<v Speaker 1>that I had happatitis B and she told me, oh,

0:02:39.520 --> 0:02:41.280
<v Speaker 1>make sure you see a doctor for it. I hadn't

0:02:41.280 --> 0:02:44.359
<v Speaker 1>seen a doctor in years at that point. So I

0:02:44.400 --> 0:02:47.840
<v Speaker 1>went in to see somebody and they did my viral

0:02:47.880 --> 0:02:50.480
<v Speaker 1>load and I did the ultrasound and everything was fine.

0:02:50.639 --> 0:02:53.600
<v Speaker 1>It was very low. I didn't need medication. And at

0:02:53.600 --> 0:02:56.320
<v Speaker 1>that point, I remember I was engaged, I think, and

0:02:56.360 --> 0:02:59.280
<v Speaker 1>so my friend had said, oh, make sure your fiance

0:02:59.400 --> 0:03:03.040
<v Speaker 1>also gets to and he ended up getting tested and

0:03:03.080 --> 0:03:05.079
<v Speaker 1>needing to get vaccinated, and you know, so that was

0:03:05.160 --> 0:03:07.400
<v Speaker 1>kind of the extent of how it impacted my life.

0:03:07.440 --> 0:03:09.560
<v Speaker 1>And I had told him about it, and I was,

0:03:09.720 --> 0:03:11.680
<v Speaker 1>you know, I was happy that he was. He didn't

0:03:11.680 --> 0:03:13.680
<v Speaker 1>make a big deal out of it, and these are

0:03:13.680 --> 0:03:15.520
<v Speaker 1>all points now looking back, I realized, you know, I

0:03:15.600 --> 0:03:17.880
<v Speaker 1>was fortunate, and so many people around the world are

0:03:17.919 --> 0:03:21.200
<v Speaker 1>not so fortunate to have, you know, a career that's

0:03:21.240 --> 0:03:25.000
<v Speaker 1>not affected by it, or a relationship that's not affected

0:03:25.000 --> 0:03:26.400
<v Speaker 1>by it. You know, there are a lot of people

0:03:26.440 --> 0:03:28.560
<v Speaker 1>who you know, lose their partners, they end up, they

0:03:28.639 --> 0:03:32.520
<v Speaker 1>may get divorced, they may get disowned by family or

0:03:32.680 --> 0:03:34.480
<v Speaker 1>unable to pursue the career they went to.

0:03:35.840 --> 0:03:36.480
<v Speaker 3>So I didn't have.

0:03:36.440 --> 0:03:41.000
<v Speaker 1>Any of that, and I got married and we got pregnant.

0:03:41.200 --> 0:03:44.320
<v Speaker 1>I've had four kids, and with each one of those kids,

0:03:44.400 --> 0:03:47.360
<v Speaker 1>especially the first one, it did hit me that, oh,

0:03:47.440 --> 0:03:49.200
<v Speaker 1>I know, there's a chance that I could pass this

0:03:49.240 --> 0:03:52.640
<v Speaker 1>affection on to my children, and that definitely weighed heavily

0:03:52.680 --> 0:03:55.120
<v Speaker 1>on me. Although I knew the research that because my

0:03:55.680 --> 0:03:58.680
<v Speaker 1>viral load was low, there would be very low chants

0:03:59.000 --> 0:04:02.960
<v Speaker 1>of the developing hep BE. But that's where I really

0:04:02.960 --> 0:04:04.560
<v Speaker 1>all of a sudden felt like, oh my gosh, you know,

0:04:04.640 --> 0:04:08.120
<v Speaker 1>this could really impact me personally. And I'm happy to

0:04:08.160 --> 0:04:10.040
<v Speaker 1>say that all for my kids are heap BE free

0:04:10.520 --> 0:04:12.280
<v Speaker 1>and that they don't have to live with this chronic

0:04:12.320 --> 0:04:15.080
<v Speaker 1>disease and worry about risk of lover cancer and other

0:04:15.120 --> 0:04:17.080
<v Speaker 1>things that other kids have to go through even now

0:04:17.120 --> 0:04:19.880
<v Speaker 1>in this day and age. And so as a physician,

0:04:19.920 --> 0:04:23.000
<v Speaker 1>I didn't particularly have an inkling that I was going

0:04:23.080 --> 0:04:26.040
<v Speaker 1>to do hepatitis work at all, And it wasn't until

0:04:26.120 --> 0:04:28.919
<v Speaker 1>I moved to New York City after I finished my

0:04:28.960 --> 0:04:32.280
<v Speaker 1>residency and I took a job with a community health

0:04:32.279 --> 0:04:36.600
<v Speaker 1>center in Chinatown. So I began serving the largely Chinese

0:04:36.640 --> 0:04:40.120
<v Speaker 1>community in Chinatown and learned so much more about HEPBE

0:04:40.200 --> 0:04:42.200
<v Speaker 1>than I ever knew. That it's, you know, one of

0:04:42.200 --> 0:04:46.480
<v Speaker 1>the most common infectious diseases around the world. Up to

0:04:46.600 --> 0:04:48.600
<v Speaker 1>like one in ten of our patients had heppy was

0:04:48.640 --> 0:04:52.560
<v Speaker 1>as common as hypertension. And whereas I had seen specialists,

0:04:52.640 --> 0:04:55.360
<v Speaker 1>you know, during residency, a lot of our patients could

0:04:55.360 --> 0:04:58.320
<v Speaker 1>not afford to see a specialist and they weren't necessarily

0:04:58.400 --> 0:05:01.360
<v Speaker 1>easily accessible. So many of us at the community health

0:05:01.360 --> 0:05:05.960
<v Speaker 1>center learned to treat hep BEE along with hypertension, diabetes,

0:05:06.000 --> 0:05:09.520
<v Speaker 1>and other chronic diseases. So during that time, I really saw,

0:05:09.920 --> 0:05:11.799
<v Speaker 1>you know, a lot of the difficulties that people face

0:05:11.920 --> 0:05:15.120
<v Speaker 1>and getting care, and so I began really advocating and

0:05:15.160 --> 0:05:18.160
<v Speaker 1>creating programs that would help people living with hepatitis be

0:05:18.680 --> 0:05:21.960
<v Speaker 1>to increase screening in the communities, linkage to care, all

0:05:21.960 --> 0:05:24.719
<v Speaker 1>these things that can happen in a very complex medical system.

0:05:25.400 --> 0:05:28.120
<v Speaker 1>We tried to create a program to kind of streamline

0:05:28.240 --> 0:05:30.200
<v Speaker 1>all of that. As I was getting more and more

0:05:30.240 --> 0:05:33.080
<v Speaker 1>immersed in, you know, really providing the care that needs

0:05:33.120 --> 0:05:36.159
<v Speaker 1>to happen, I really had the hat on, like, you know,

0:05:36.279 --> 0:05:38.760
<v Speaker 1>the physician hat, like this is what needs to be done,

0:05:39.279 --> 0:05:41.800
<v Speaker 1>these are the interventions, this is the science behind it.

0:05:42.279 --> 0:05:44.760
<v Speaker 1>I did not wear the patient hat at all in

0:05:44.839 --> 0:05:46.920
<v Speaker 1>terms of what it meant for me, and I kind

0:05:46.920 --> 0:05:49.599
<v Speaker 1>of didn't feel like that that was my role, and

0:05:49.640 --> 0:05:52.120
<v Speaker 1>it wasn't until somebody did an interview. Actually, I did

0:05:52.160 --> 0:05:54.920
<v Speaker 1>an interview for CDC, and it was the first time,

0:05:55.040 --> 0:05:56.920
<v Speaker 1>like on camera that I had I said, you know,

0:05:57.000 --> 0:06:00.240
<v Speaker 1>I'm actually living with hepatitis B myself. And at that

0:06:00.240 --> 0:06:02.960
<v Speaker 1>point I had already occasionally mentioned it to patients. So

0:06:03.040 --> 0:06:04.920
<v Speaker 1>if I was counseling a patient who had been newly

0:06:04.960 --> 0:06:06.919
<v Speaker 1>diagnosed with HEPPY and I could see they were really

0:06:06.920 --> 0:06:11.280
<v Speaker 1>distraught or felt really overwhelmed, I would share with them

0:06:11.320 --> 0:06:13.159
<v Speaker 1>that I also was living with hep BEE. I was

0:06:13.279 --> 0:06:15.120
<v Speaker 1>just like them. I had to go for blood tests

0:06:15.279 --> 0:06:17.360
<v Speaker 1>and I think that really helped them see that it's

0:06:17.440 --> 0:06:21.039
<v Speaker 1>possible to live a happy, healthy life and it's not

0:06:21.080 --> 0:06:23.880
<v Speaker 1>a death sentence. So I was using that more often,

0:06:23.880 --> 0:06:26.960
<v Speaker 1>but I'd never spoken about it publicly, so it took

0:06:26.960 --> 0:06:29.080
<v Speaker 1>me a while. And what I've seen as a physician,

0:06:29.120 --> 0:06:31.440
<v Speaker 1>which I think as physicians we don't quite get, is

0:06:31.560 --> 0:06:35.400
<v Speaker 1>just how powerful that personal experience is. And I have

0:06:35.720 --> 0:06:39.240
<v Speaker 1>only learned this through other people. Somebody asked me to

0:06:39.240 --> 0:06:41.600
<v Speaker 1>get involved with the World Hepatitis Alliance, which is led

0:06:41.600 --> 0:06:44.440
<v Speaker 1>by patients, and through that on the board. The board

0:06:44.520 --> 0:06:48.280
<v Speaker 1>is all patients who represent each of the WHO regions.

0:06:48.880 --> 0:06:51.400
<v Speaker 1>And I heard specifically from a good friend of mine

0:06:51.440 --> 0:06:53.080
<v Speaker 1>who was now a good friend of my d lee,

0:06:53.080 --> 0:06:56.279
<v Speaker 1>who represented the Whippo region, the Western Pacific region. He

0:06:56.360 --> 0:06:59.240
<v Speaker 1>told me all these stories of people who really had

0:06:59.320 --> 0:07:03.040
<v Speaker 1>happy drastically empire their life in ways that us in

0:07:03.080 --> 0:07:04.000
<v Speaker 1>medicine don't measure.

0:07:04.080 --> 0:07:04.240
<v Speaker 3>Right.

0:07:04.279 --> 0:07:08.039
<v Speaker 1>We measure the outcomes. We look at our morbidity, mortality,

0:07:08.480 --> 0:07:14.160
<v Speaker 1>life expectancy right soorrhosis, lever cancer. We don't look at

0:07:14.520 --> 0:07:18.000
<v Speaker 1>outcomes in terms of somebody's quality of life. You know,

0:07:18.000 --> 0:07:22.520
<v Speaker 1>when I hear these stories of how people have suffered

0:07:22.840 --> 0:07:24.800
<v Speaker 1>with the burden of the disease, even if they are

0:07:25.200 --> 0:07:26.920
<v Speaker 1>I mean, as a doctor, if you were to look

0:07:26.960 --> 0:07:29.160
<v Speaker 1>at them, they would look healthy. You would tell them.

0:07:29.200 --> 0:07:31.720
<v Speaker 1>They're perfectly healthy, their liver enzymes are normal, their viral

0:07:31.760 --> 0:07:33.840
<v Speaker 1>load is low. Like you know, I only need to

0:07:33.840 --> 0:07:35.240
<v Speaker 1>see you once a year. You're fine. You know, in

0:07:35.280 --> 0:07:37.640
<v Speaker 1>our mind we think it's we think it's nothing like

0:07:37.760 --> 0:07:39.880
<v Speaker 1>if you were to then delve into how they feel

0:07:39.920 --> 0:07:42.320
<v Speaker 1>about themselves, and most patients won't even tell me that.

0:07:42.400 --> 0:07:44.880
<v Speaker 1>So I know that what I see, what I glimpse

0:07:44.960 --> 0:07:48.240
<v Speaker 1>in my exam room is just such a small part

0:07:48.320 --> 0:07:50.840
<v Speaker 1>of what it means for them to live with a disease.

0:07:50.880 --> 0:07:54.040
<v Speaker 1>And so you know, it's beyond just like keeping them

0:07:54.120 --> 0:07:58.000
<v Speaker 1>from getting sorosis and liver cancer. You know, us in medicine,

0:07:58.040 --> 0:08:01.360
<v Speaker 1>if we're if our mission is to prove quality of

0:08:01.400 --> 0:08:04.840
<v Speaker 1>life and decrease burden of disease on people's lives, we

0:08:04.920 --> 0:08:08.480
<v Speaker 1>have to think outside just you know, our our biochemical tests.

0:08:09.920 --> 0:08:11.800
<v Speaker 1>I think, you know, I've just learned that we can't

0:08:11.840 --> 0:08:14.480
<v Speaker 1>afford to operate in our silos, right, the scientists cannot

0:08:14.520 --> 0:08:17.960
<v Speaker 1>afford to operate in you know, their silos only like

0:08:18.000 --> 0:08:21.440
<v Speaker 1>publishing to the scientific community and having meetings that are

0:08:21.440 --> 0:08:24.720
<v Speaker 1>only for scientists and medical researchers. But we have to

0:08:24.720 --> 0:08:27.000
<v Speaker 1>get out of the box. We have to combine. You know,

0:08:27.040 --> 0:08:30.120
<v Speaker 1>the people living with the disease have to work in

0:08:30.200 --> 0:08:32.320
<v Speaker 1>concert with the medical community if we're really going to

0:08:32.320 --> 0:08:35.760
<v Speaker 1>make progress for elimination and for uh you know, really

0:08:35.760 --> 0:09:14.800
<v Speaker 1>alleviating the suffering of be on people's lives.

0:09:23.440 --> 0:09:26.400
<v Speaker 2>Thank you so much, doctor Wong for sharing your story.

0:09:26.920 --> 0:09:30.760
<v Speaker 2>Thank you. Hi. I'm Aaron Welsh and.

0:09:30.720 --> 0:09:32.520
<v Speaker 3>I'm Aaron Alman Updyke.

0:09:32.679 --> 0:09:35.920
<v Speaker 2>And this is this podcast will Kill You.

0:09:36.040 --> 0:09:38.079
<v Speaker 3>Welcome to another episode.

0:09:38.480 --> 0:09:44.120
<v Speaker 2>Yes, welcome, Welcome. As you have probably gathered, we are

0:09:44.160 --> 0:09:49.040
<v Speaker 2>going to be talking about another hepatitis virus, our second

0:09:49.040 --> 0:09:54.079
<v Speaker 2>podcast history. Yes, this one hepatitis B. Yeah, we started

0:09:54.120 --> 0:09:58.360
<v Speaker 2>with C. Now we're going to be what's next? Uh, well,

0:09:58.400 --> 0:10:01.520
<v Speaker 2>I am going to mention D. I figured.

0:10:03.520 --> 0:10:04.560
<v Speaker 3>I think next will be A.

0:10:05.240 --> 0:10:08.800
<v Speaker 2>Yeah, next will definitely be A, and then we'll have

0:10:08.840 --> 0:10:10.679
<v Speaker 2>to do E. And then maybe by the time that

0:10:10.720 --> 0:10:12.000
<v Speaker 2>comes out, there'll be a few.

0:10:11.760 --> 0:10:14.960
<v Speaker 3>More and we can cover all in one quite possible.

0:10:15.360 --> 0:10:19.040
<v Speaker 2>Well, Aaron, what time is it?

0:10:19.040 --> 0:10:21.119
<v Speaker 3>It's quarantiny time, Aaron.

0:10:21.280 --> 0:10:24.400
<v Speaker 2>It is. And what are we drinking this week?

0:10:24.559 --> 0:10:26.359
<v Speaker 3>We're drinking the beasting.

0:10:27.000 --> 0:10:31.880
<v Speaker 2>We are appatitis B, hepatitis B. And what is in

0:10:31.960 --> 0:10:32.560
<v Speaker 2>the beasting?

0:10:33.120 --> 0:10:37.440
<v Speaker 3>Well, it's a lovely little bev a ginger mint syrup,

0:10:37.960 --> 0:10:42.560
<v Speaker 3>some lemon juice, club soda. If you're drinking alcohol, you

0:10:42.600 --> 0:10:44.120
<v Speaker 3>could certainly put some gin in it.

0:10:44.520 --> 0:10:48.160
<v Speaker 2>That will be the little sting. But otherwise on its own,

0:10:48.800 --> 0:10:53.439
<v Speaker 2>it is delicious, very refreshing. I just I love it,

0:10:55.080 --> 0:10:58.880
<v Speaker 2>and we will post the full recipe for this quarantini

0:10:59.040 --> 0:11:01.960
<v Speaker 2>as well as our non alcoholic Placey Brita on our

0:11:01.960 --> 0:11:05.199
<v Speaker 2>website This podcast Willkill You dot com, as well as

0:11:05.240 --> 0:11:06.960
<v Speaker 2>on all of our social media channels.

0:11:07.520 --> 0:11:10.120
<v Speaker 3>On our website This Podcast will Kill You dot Com,

0:11:10.600 --> 0:11:13.520
<v Speaker 3>you will find any and every of the things that

0:11:13.559 --> 0:11:16.120
<v Speaker 3>you ever wanted to know about the podcast. You can

0:11:16.160 --> 0:11:19.320
<v Speaker 3>find Bloodmobile, who does all of our music, and the

0:11:19.360 --> 0:11:23.200
<v Speaker 3>link to their Spotify. You can find merch all of

0:11:23.240 --> 0:11:27.240
<v Speaker 3>our merch. You can find transcripts for all of our episodes.

0:11:27.480 --> 0:11:32.040
<v Speaker 3>You can find a bookshop dot org affiliate account, and

0:11:32.520 --> 0:11:35.079
<v Speaker 3>a good Reads list. You can find all You're doing

0:11:35.120 --> 0:11:36.800
<v Speaker 3>great things for all of our episodes.

0:11:36.840 --> 0:11:37.080
<v Speaker 2>Thanks.

0:11:37.120 --> 0:11:41.360
<v Speaker 3>I need the encouragement, and you can find our Patreon.

0:11:41.640 --> 0:11:45.679
<v Speaker 2>Wow, that was impressive. Thank you.

0:11:45.840 --> 0:11:46.160
<v Speaker 3>Thanks.

0:11:46.400 --> 0:11:48.400
<v Speaker 2>I'm always relieved when I don't have to do it.

0:11:49.040 --> 0:11:51.959
<v Speaker 3>I always get really nervous and then I just power through.

0:11:52.400 --> 0:11:54.360
<v Speaker 2>I like it. It's like you get in the zone

0:11:54.400 --> 0:12:01.040
<v Speaker 2>and then you're there. Well before we get into the episode,

0:12:01.480 --> 0:12:04.880
<v Speaker 2>I wanted to mention one thing because Endometriosis, which is

0:12:05.160 --> 0:12:08.600
<v Speaker 2>the last episode we released, is still on my mind.

0:12:08.720 --> 0:12:11.960
<v Speaker 2>Even though I've been reading a lot about happatitis B,

0:12:12.160 --> 0:12:15.120
<v Speaker 2>I still have these like little thoughts of endo that

0:12:15.160 --> 0:12:19.160
<v Speaker 2>pop in, and I realized that there was like one

0:12:19.200 --> 0:12:23.120
<v Speaker 2>more thing that I wanted to say. Also, like Endometriosis,

0:12:23.160 --> 0:12:27.200
<v Speaker 2>we've recorded it, it's not yet released, and so maybe

0:12:27.240 --> 0:12:29.520
<v Speaker 2>people will have already said this by the time this

0:12:29.600 --> 0:12:31.400
<v Speaker 2>comes out. It's sort of a weird time travel thing

0:12:31.440 --> 0:12:35.320
<v Speaker 2>we're doing here. Yeah, But in the Endometriosis episode, we

0:12:35.440 --> 0:12:40.680
<v Speaker 2>talked about how often complete or partial hysterectomy is recommended

0:12:41.120 --> 0:12:46.000
<v Speaker 2>as like a cure for endometriosis, which it isn't, and

0:12:46.440 --> 0:12:49.600
<v Speaker 2>which that can also add another dimension of pain and

0:12:49.679 --> 0:12:53.880
<v Speaker 2>anguish to an already difficult disease. But I also think

0:12:53.920 --> 0:12:57.280
<v Speaker 2>that another aspect to that that we didn't really touch on,

0:12:57.520 --> 0:13:00.160
<v Speaker 2>and I think is important to mention, is that there

0:13:00.200 --> 0:13:03.359
<v Speaker 2>can also be a reluctance on the part of physicians

0:13:03.360 --> 0:13:07.559
<v Speaker 2>to perform hysterectomies or even just tubal ligations, like getting

0:13:07.559 --> 0:13:11.000
<v Speaker 2>your tubes tied for whatever reason, even if that reason

0:13:11.120 --> 0:13:13.600
<v Speaker 2>is I don't want to have any children or any

0:13:13.640 --> 0:13:16.960
<v Speaker 2>more children, a lot of people are just told, oh,

0:13:17.000 --> 0:13:19.079
<v Speaker 2>you're just too young. You might change your mind and

0:13:19.120 --> 0:13:21.319
<v Speaker 2>want to have kids in the future. And so really

0:13:21.360 --> 0:13:24.040
<v Speaker 2>that's sort of another way in which many times physicians

0:13:24.080 --> 0:13:27.720
<v Speaker 2>don't fulfill the very basic requirement of listening to their patient,

0:13:27.800 --> 0:13:30.760
<v Speaker 2>and how the social and gender role of someone can

0:13:30.800 --> 0:13:34.880
<v Speaker 2>be held as more important than what they want than

0:13:34.920 --> 0:13:35.480
<v Speaker 2>their wishes.

0:13:35.960 --> 0:13:36.480
<v Speaker 3>Yeah.

0:13:36.840 --> 0:13:39.120
<v Speaker 2>Anyway, that just kept like circulating in my head and

0:13:39.120 --> 0:13:40.840
<v Speaker 2>I was like, oh, gosh, I need to say it.

0:13:42.480 --> 0:13:45.080
<v Speaker 2>So yeah, okay, got it out.

0:13:45.440 --> 0:13:48.440
<v Speaker 3>Yeah, that's an incredibly important point.

0:13:49.200 --> 0:13:53.800
<v Speaker 2>Okay, should we move on to the actual topic of

0:13:53.840 --> 0:13:54.600
<v Speaker 2>today's episode.

0:13:54.679 --> 0:13:58.920
<v Speaker 3>Today's topic hepatitis B. Let's take a quick break and

0:13:58.960 --> 0:14:34.920
<v Speaker 3>then get into the biology. So, like you mentioned erin,

0:14:35.320 --> 0:14:39.760
<v Speaker 3>this is our second hepatitis virus, and I know for

0:14:39.840 --> 0:14:43.480
<v Speaker 3>sure that during our hepatitis C episode we talked at

0:14:43.560 --> 0:14:50.080
<v Speaker 3>least a little bit about how all the hepatiti all

0:14:50.120 --> 0:14:53.760
<v Speaker 3>the hepatitis viruses are named, not for anything that links

0:14:53.800 --> 0:14:57.240
<v Speaker 3>the particular viruses together, aside from the fact that they

0:14:57.280 --> 0:15:02.720
<v Speaker 3>all predominantly affect the liver. So there are five predominant

0:15:02.760 --> 0:15:06.280
<v Speaker 3>viruses which we kind of already named at the beginning, A, B, C, D,

0:15:06.400 --> 0:15:11.160
<v Speaker 3>and E. And today we're focusing on hepatitis B, and

0:15:11.240 --> 0:15:14.640
<v Speaker 3>I will mention hepatitis D and you'll understand why in

0:15:14.680 --> 0:15:19.080
<v Speaker 3>a minute if you don't already know the little interplay

0:15:19.120 --> 0:15:24.680
<v Speaker 3>between hepatitis D and B. All right, hepatitis B. It's

0:15:24.720 --> 0:15:30.760
<v Speaker 3>in the family Hepadnavii day, which essentially just means viruses

0:15:30.800 --> 0:15:35.280
<v Speaker 3>that affect the liver, like no surprise, straightforward. One thing

0:15:35.320 --> 0:15:38.000
<v Speaker 3>that's there's a lot of interesting things about the virology

0:15:38.080 --> 0:15:40.360
<v Speaker 3>of hepatitis B, and I'm probably not even going to

0:15:40.440 --> 0:15:45.080
<v Speaker 3>do them justice, but here we try. Hepatitis B virus

0:15:45.160 --> 0:15:49.720
<v Speaker 3>is a partially double stranded DNA virus, which is weird.

0:15:50.720 --> 0:15:53.360
<v Speaker 3>So it has a genome that it's like in a

0:15:53.400 --> 0:15:57.280
<v Speaker 3>little circle, and part of it is double stranded and

0:15:57.320 --> 0:15:59.960
<v Speaker 3>part of it is single stranded, which is very bizarre.

0:16:00.720 --> 0:16:01.840
<v Speaker 3>Do you have a question already?

0:16:01.920 --> 0:16:05.360
<v Speaker 2>Erin I can see, I mean yes, but I'm waiting,

0:16:05.960 --> 0:16:06.640
<v Speaker 2>being patient.

0:16:06.760 --> 0:16:11.200
<v Speaker 3>Okay, we'll see if I have any answers. Hepatitis B

0:16:11.320 --> 0:16:14.960
<v Speaker 3>virus has a lot of different genotypes that vary very

0:16:15.040 --> 0:16:19.960
<v Speaker 3>widely in their overall geographic distribution. However, as we mentioned

0:16:20.040 --> 0:16:22.480
<v Speaker 3>up top, and as we'll talk a lot about towards

0:16:22.480 --> 0:16:25.840
<v Speaker 3>the end of this episode, this is a globally distributed,

0:16:26.320 --> 0:16:28.280
<v Speaker 3>incredibly prevalent.

0:16:27.960 --> 0:16:32.560
<v Speaker 2>Virus, like incredibly incredibly prevalent.

0:16:33.040 --> 0:16:35.400
<v Speaker 3>And it's still, as far as I can tell a

0:16:35.400 --> 0:16:38.880
<v Speaker 3>little bit up for debate whether these different genotypes really

0:16:38.960 --> 0:16:41.800
<v Speaker 3>vary in their tendency to cause chronic infection or in

0:16:41.880 --> 0:16:44.800
<v Speaker 3>their overall disease course. A lot of sources I read

0:16:44.880 --> 0:16:48.040
<v Speaker 3>said that yes, different genotypes kind of have different tendencies

0:16:48.160 --> 0:16:53.120
<v Speaker 3>or characteristics, and some said it's up for debate, so okay.

0:16:53.720 --> 0:16:56.760
<v Speaker 3>But being a virus, this is of course a pathogen

0:16:56.760 --> 0:16:59.880
<v Speaker 3>that has to find its way into our cells, and

0:17:00.040 --> 0:17:03.640
<v Speaker 3>being a virus that infects the liver, it's unsurprising that

0:17:03.720 --> 0:17:07.000
<v Speaker 3>the primary cell type that it infects is our hepatocites,

0:17:07.119 --> 0:17:11.600
<v Speaker 3>our actual liver cells, not the blood vessels in our liver,

0:17:12.040 --> 0:17:15.560
<v Speaker 3>not any of the other things around there, but generally

0:17:15.680 --> 0:17:17.600
<v Speaker 3>our liver cells.

0:17:17.640 --> 0:17:19.600
<v Speaker 2>The things that make up the meat.

0:17:19.840 --> 0:17:24.080
<v Speaker 3>Of the liver exactly, also called the paranama of the liver,

0:17:25.160 --> 0:17:26.160
<v Speaker 3>the fancy word for.

0:17:26.160 --> 0:17:26.840
<v Speaker 2>The meat.

0:17:29.400 --> 0:17:33.879
<v Speaker 3>So hepatitis B is transmitted in very similar ways to

0:17:33.920 --> 0:17:39.080
<v Speaker 3>hepatitis C, as you may remember from several seasons ago now,

0:17:39.160 --> 0:17:44.360
<v Speaker 3>but with a few important caveats. So, hepatitis B can

0:17:44.400 --> 0:17:47.560
<v Speaker 3>be a blood born virus, So anything that involves the

0:17:47.600 --> 0:17:51.920
<v Speaker 3>sharing of blood, whether that's contaminated needles in the healthcare

0:17:51.920 --> 0:17:56.320
<v Speaker 3>setting or in intravenous drug use settings, it can be

0:17:56.359 --> 0:17:59.720
<v Speaker 3>transmitted via blood transfusions, and of course is something that

0:17:59.720 --> 0:18:01.640
<v Speaker 3>we see screen for to try and reduce the.

0:18:01.640 --> 0:18:02.119
<v Speaker 2>Risk of that.

0:18:03.440 --> 0:18:08.200
<v Speaker 3>But hepatitis B is also much more easily transmitted sexually

0:18:08.240 --> 0:18:13.119
<v Speaker 3>compared to hepatitis C. It's present in so many bodily fluids.

0:18:13.680 --> 0:18:14.640
<v Speaker 2>Why is that?

0:18:15.400 --> 0:18:20.080
<v Speaker 3>It's a really good question. I imagine it is largely

0:18:20.119 --> 0:18:25.000
<v Speaker 3>because hepatitis B is very very infectious. As an example,

0:18:26.000 --> 0:18:30.160
<v Speaker 3>according to WHO, it's fifty to one hundred times more

0:18:30.240 --> 0:18:33.159
<v Speaker 3>infectious than HIV WHOA.

0:18:33.440 --> 0:18:37.160
<v Speaker 2>So I know, do we know the reasons for that

0:18:37.480 --> 0:18:39.320
<v Speaker 2>increased infectivity.

0:18:39.720 --> 0:18:43.800
<v Speaker 3>Oh, that's a very good question. I do not, Okay, yeah,

0:18:43.840 --> 0:18:46.479
<v Speaker 3>And I don't also have numbers on like the actual

0:18:46.560 --> 0:18:49.920
<v Speaker 3>infectious dose. I couldn't find a solid answer on that either.

0:18:51.000 --> 0:18:53.600
<v Speaker 3>I do know that it can persist in the environment

0:18:53.880 --> 0:18:56.119
<v Speaker 3>for at least several days. So I think it's a

0:18:56.160 --> 0:18:59.440
<v Speaker 3>pretty hardy virus, so that might be part of it.

0:18:59.560 --> 0:19:06.000
<v Speaker 2>Yeah, Okay, So going back real quick, partially double stranded,

0:19:06.080 --> 0:19:09.399
<v Speaker 2>what's the implication of that in like a virology sense?

0:19:09.440 --> 0:19:12.760
<v Speaker 3>So it's really interesting. Hepatitis B is one of the

0:19:12.840 --> 0:19:16.800
<v Speaker 3>few viruses that's not an RNA virus but uses a

0:19:17.040 --> 0:19:21.040
<v Speaker 3>reverse transcriptase in order to replicate its genome. So HIV

0:19:21.560 --> 0:19:25.560
<v Speaker 3>is an RNA virus that relies on an enzyme reverse

0:19:25.600 --> 0:19:29.840
<v Speaker 3>transcriptase to make a form of DNA in order to

0:19:29.880 --> 0:19:34.399
<v Speaker 3>then replicate, and B also does even though it's a

0:19:34.520 --> 0:19:35.480
<v Speaker 3>DNA virus.

0:19:36.280 --> 0:19:39.080
<v Speaker 2>That is so bizarre, and so I definitely came across

0:19:39.080 --> 0:19:42.440
<v Speaker 2>some of that in the evolution behabers because it kind

0:19:42.440 --> 0:19:44.679
<v Speaker 2>of throws a wrench in things as to like the

0:19:44.800 --> 0:19:48.680
<v Speaker 2>mutation rates, the scale of the molecular clock, blah blah blahh.

0:19:48.400 --> 0:19:50.440
<v Speaker 3>Yeah, and it also, as I'll kind of talk a

0:19:50.480 --> 0:19:53.480
<v Speaker 3>little bit more about later, it allows it to integrate

0:19:53.560 --> 0:19:56.719
<v Speaker 3>into our genome in a way that then sets us

0:19:56.800 --> 0:20:01.920
<v Speaker 3>up for both chronic infection and also potentially cancer right

0:20:01.960 --> 0:20:03.399
<v Speaker 3>and cancer causing mutations.

0:20:03.600 --> 0:20:11.879
<v Speaker 2>Aha, spoilers do other viruses have this partially double stranded

0:20:12.000 --> 0:20:14.520
<v Speaker 2>DNA thing as well.

0:20:14.680 --> 0:20:17.080
<v Speaker 3>I don't know of any other human viruses, but I

0:20:17.119 --> 0:20:19.840
<v Speaker 3>know that there are other animal hepatnaviruses that do.

0:20:19.880 --> 0:20:24.119
<v Speaker 2>Right, Okay, those so that's like the unifying future of hepatnaviruses.

0:20:24.160 --> 0:20:30.600
<v Speaker 3>Okay, yeah, yeah, wow cool? Okay, So hepatitis B is

0:20:30.680 --> 0:20:34.840
<v Speaker 3>also transmitted back to that part of it vertically at

0:20:34.920 --> 0:20:36.280
<v Speaker 3>much higher rates.

0:20:36.760 --> 0:20:36.920
<v Speaker 2>This.

0:20:37.640 --> 0:20:39.679
<v Speaker 3>Let me tell you some numbers. The estimates that I

0:20:39.720 --> 0:20:44.920
<v Speaker 3>read ranged from forty to ninety percent of babies born

0:20:45.000 --> 0:20:48.159
<v Speaker 3>to people living with hepatitis B with chronic hepatitis B

0:20:48.880 --> 0:20:52.960
<v Speaker 3>will become infected with hepatitis if they are not treated.

0:20:53.440 --> 0:20:54.000
<v Speaker 2>Wow.

0:20:54.160 --> 0:20:58.040
<v Speaker 3>And this is in comparison to only six percent of

0:20:58.160 --> 0:21:02.199
<v Speaker 3>people with hepatitis C will then transmit hepatitis C to

0:21:02.280 --> 0:21:03.000
<v Speaker 3>their offspring.

0:21:03.800 --> 0:21:06.359
<v Speaker 2>What is the reason for that difference?

0:21:06.720 --> 0:21:11.520
<v Speaker 3>Again, I think it's largely just how infectious hepatitis B is. Okay,

0:21:11.840 --> 0:21:14.560
<v Speaker 3>But here's something that I think is very interesting and

0:21:15.080 --> 0:21:20.080
<v Speaker 3>important about this vertical transmission of hepatitis B. First of all,

0:21:20.160 --> 0:21:22.639
<v Speaker 3>a lot of times when we talk about vertical transmissions,

0:21:22.680 --> 0:21:27.520
<v Speaker 3>so from parent to offspring, it's wind viruses or bacteria

0:21:27.760 --> 0:21:32.239
<v Speaker 3>can cross the placenta and infective fetus during pregnancy. That

0:21:32.359 --> 0:21:35.800
<v Speaker 3>is not what happens in hepatitis B. The transmission is

0:21:35.840 --> 0:21:40.800
<v Speaker 3>not transplacental. In the vast, vast majority of cases, it's

0:21:40.960 --> 0:21:45.760
<v Speaker 3>happening during the process of childbirth, and it's not happening

0:21:46.080 --> 0:21:50.639
<v Speaker 3>during breastfeeding. It's not happening during pregnancy crossing the placenta.

0:21:50.720 --> 0:21:56.560
<v Speaker 3>It's happening specifically during the period of childbirth, whether that

0:21:56.680 --> 0:22:02.399
<v Speaker 3>birth happens vaginally or VC section. What there is some

0:22:02.600 --> 0:22:05.520
<v Speaker 3>papers that suggest that C section delivery is a slightly

0:22:05.760 --> 0:22:10.680
<v Speaker 3>lower risk, but it's not conclusive. And if you've ever

0:22:10.720 --> 0:22:13.720
<v Speaker 3>seen a delivery of either kind, it kind of makes

0:22:13.760 --> 0:22:17.200
<v Speaker 3>sense because neither one is really less bloody than the other,

0:22:17.640 --> 0:22:20.760
<v Speaker 3>and so many bodily fluids are being exchanged no matter

0:22:20.840 --> 0:22:22.440
<v Speaker 3>what exit root a baby takes.

0:22:22.840 --> 0:22:25.920
<v Speaker 2>It's so it's just like the blood and bodily fluids.

0:22:25.560 --> 0:22:29.560
<v Speaker 3>Blood bodily fluids. It's thought that cervical secretions. So if

0:22:29.560 --> 0:22:32.240
<v Speaker 3>a baby comes out vaginally, and that's why maybe there's

0:22:32.240 --> 0:22:34.840
<v Speaker 3>some thought that it's a slightly higher risk, but the

0:22:34.920 --> 0:22:40.920
<v Speaker 3>data hasn't really borne that out necessarily. What that's very interesting,

0:22:41.040 --> 0:22:43.360
<v Speaker 3>I know, because I didn't really realize that I kind

0:22:43.400 --> 0:22:46.520
<v Speaker 3>of thought that it was something that could be transmitted transpolacentally.

0:22:47.000 --> 0:22:51.000
<v Speaker 3>Yet it's not, and that is really important when we

0:22:51.040 --> 0:22:55.360
<v Speaker 3>talk about how to treat and prevent hepatitis B infection.

0:22:55.560 --> 0:22:56.600
<v Speaker 2>So let me.

0:22:56.800 --> 0:23:02.440
<v Speaker 3>Keep going, shall I? You shall The incubation period of infection,

0:23:02.560 --> 0:23:05.200
<v Speaker 3>the time from when someone gets infected to when they

0:23:05.240 --> 0:23:10.639
<v Speaker 3>show symptoms, can really range anywhere from thirty days to

0:23:10.880 --> 0:23:15.600
<v Speaker 3>up to six months. And I think that this incubation period,

0:23:16.240 --> 0:23:20.439
<v Speaker 3>even noting it incubation period, is interesting because hepatitis B

0:23:21.600 --> 0:23:26.560
<v Speaker 3>is a virus that can be entirely asymptomatic, and chronic

0:23:26.680 --> 0:23:30.960
<v Speaker 3>infection is generally defined as the persistence of a specific

0:23:31.000 --> 0:23:35.679
<v Speaker 3>anigen being able to detect hepatitis b's surface antigen for

0:23:35.920 --> 0:23:39.720
<v Speaker 3>a period of at least six months. So it's interesting

0:23:39.760 --> 0:23:42.320
<v Speaker 3>that you can also say the incubation period itself might

0:23:42.359 --> 0:23:45.680
<v Speaker 3>be six months before you show symptoms, but you also

0:23:45.720 --> 0:23:47.000
<v Speaker 3>might never show symptoms.

0:23:47.800 --> 0:23:51.560
<v Speaker 2>Yeah. Yeah, that makes it really difficult to calculate an

0:23:51.560 --> 0:23:53.919
<v Speaker 2>incubation exactly. It sure does.

0:23:56.320 --> 0:23:59.800
<v Speaker 3>So let's talk briefly about what the symptoms can be

0:24:00.480 --> 0:24:04.080
<v Speaker 3>if people do have kind of an acute infection or

0:24:04.800 --> 0:24:09.360
<v Speaker 3>you know, symptoms with an initial infection. Most of the time,

0:24:09.400 --> 0:24:14.280
<v Speaker 3>of course, it's completely asymptomatic or very minimally symptomatic. And

0:24:14.480 --> 0:24:18.199
<v Speaker 3>it's important to note that some people can clear the

0:24:18.280 --> 0:24:22.639
<v Speaker 3>virus entirely from their system after an acute infection, whether

0:24:22.680 --> 0:24:27.240
<v Speaker 3>they show symptoms or not. But we'll talk about how

0:24:27.280 --> 0:24:29.160
<v Speaker 3>that doesn't happen for a lot of people and who

0:24:29.160 --> 0:24:32.760
<v Speaker 3>those people are and why. Okay, okay, But when symptoms

0:24:32.800 --> 0:24:36.680
<v Speaker 3>do occur in the case of an acute infection, they

0:24:37.000 --> 0:24:39.840
<v Speaker 3>really don't look any different from a lot of the

0:24:39.960 --> 0:24:44.639
<v Speaker 3>other viruses and pathogens that affect our liver, including hepatitis C.

0:24:45.840 --> 0:24:49.520
<v Speaker 3>So hepatitis B is less likely to cause acute liver

0:24:49.760 --> 0:24:55.560
<v Speaker 3>failure completely, but it can cause things like jaundice, where

0:24:55.720 --> 0:24:58.120
<v Speaker 3>your skin can become yellow, or the whites of your

0:24:58.160 --> 0:25:02.040
<v Speaker 3>eyes and your gums, things like that that become yellowish.

0:25:02.119 --> 0:25:05.719
<v Speaker 3>And this occurs because our liver is what conjugates and

0:25:05.760 --> 0:25:11.240
<v Speaker 3>helps eliminate bilirubin from our bodies, and so without that process, bilirubin,

0:25:11.359 --> 0:25:13.879
<v Speaker 3>which is a breakdown product of our red blood cells,

0:25:14.560 --> 0:25:17.120
<v Speaker 3>builds up in our skin and our eyes, and that's

0:25:17.160 --> 0:25:21.240
<v Speaker 3>what turns us yellow. It then also causes a lot

0:25:21.280 --> 0:25:25.000
<v Speaker 3>of nausea and vomiting from this buildup of not just bilirubin,

0:25:25.040 --> 0:25:27.840
<v Speaker 3>but a lot of stuff in our system that our

0:25:27.880 --> 0:25:32.000
<v Speaker 3>liver is supposed to filter out. It causes abdominal pain

0:25:32.200 --> 0:25:35.760
<v Speaker 3>because your liver is inflamed, and even though your liver

0:25:35.840 --> 0:25:40.000
<v Speaker 3>itself doesn't have sensory innervation, this inflammation can reach the

0:25:40.080 --> 0:25:43.200
<v Speaker 3>lining of the liver, the lining of the abdominal cavity

0:25:43.240 --> 0:25:47.719
<v Speaker 3>and cause pretty severe abdominal pain. And then all of

0:25:47.760 --> 0:25:51.560
<v Speaker 3>these toxins that can accumulate in your bloodstream can cause

0:25:51.600 --> 0:25:55.119
<v Speaker 3>severe fatigue. It can cause a darkening of your urine

0:25:55.160 --> 0:25:57.960
<v Speaker 3>as the bilirubin tries to be excreted through your urine

0:25:58.000 --> 0:26:02.439
<v Speaker 3>instead of your poop, and in very rare cases it

0:26:02.480 --> 0:26:07.080
<v Speaker 3>can cause actual acute onset liver failure, which can be fatal,

0:26:08.160 --> 0:26:13.040
<v Speaker 3>but much more commonly, liver failure happens as a progressive

0:26:13.119 --> 0:26:20.560
<v Speaker 3>process of long term inflammation, leading to cirrhosis and fibrosis

0:26:21.040 --> 0:26:27.439
<v Speaker 3>and potentially hepatocellular carcinoma or cancer. So I want to

0:26:27.480 --> 0:26:32.560
<v Speaker 3>focus on this, this chronic infection of hepatitis B, because

0:26:33.320 --> 0:26:35.720
<v Speaker 3>it's not only very interesting, but it's also the most

0:26:35.720 --> 0:26:41.320
<v Speaker 3>important part of this virus. So, first of all, the

0:26:41.680 --> 0:26:48.560
<v Speaker 3>likelihood of a chronic infection becoming established varies person to person,

0:26:49.440 --> 0:26:53.320
<v Speaker 3>and it's inversely related to the age at which you

0:26:53.400 --> 0:26:59.640
<v Speaker 3>become exposed and infected. So for infants, for neonates who

0:26:59.640 --> 0:27:04.600
<v Speaker 3>get infected vertically during birth, the likelihood of a chronic

0:27:04.720 --> 0:27:12.159
<v Speaker 3>infection is over ninety percent over ninety percent, So that

0:27:12.280 --> 0:27:16.480
<v Speaker 3>means that almost all babies that become infected at birth

0:27:16.560 --> 0:27:20.720
<v Speaker 3>or shortly thereafter go on to have a chronic lifelong

0:27:20.880 --> 0:27:25.600
<v Speaker 3>infection with a very significant risk of progression to fibrosis

0:27:26.080 --> 0:27:28.160
<v Speaker 3>and or liver cancer.

0:27:28.840 --> 0:27:32.560
<v Speaker 2>So this inverse relationship, is it like a straight line

0:27:32.800 --> 0:27:34.880
<v Speaker 2>or does it kind of have any sort of peaks

0:27:34.880 --> 0:27:35.600
<v Speaker 2>and valleys.

0:27:35.680 --> 0:27:40.439
<v Speaker 3>It's not a straight line, it's a it's a well,

0:27:40.560 --> 0:27:44.160
<v Speaker 3>what do you call it? No, it's a what a zoop? Maybe?

0:27:44.320 --> 0:27:46.040
<v Speaker 2>What do you call it? Sigmore a jay?

0:27:46.560 --> 0:27:50.280
<v Speaker 3>So let me just tell you numbers, because I'm clearly

0:27:50.320 --> 0:27:56.800
<v Speaker 3>not doing a good job swooping. So infant neonate ninety

0:27:56.840 --> 0:28:00.439
<v Speaker 3>percent chance a child if they get in afected when

0:28:00.440 --> 0:28:03.320
<v Speaker 3>they're young, like between ages one to five, the risk

0:28:03.400 --> 0:28:06.159
<v Speaker 3>of chronic infection is like thirty percent. So it's a

0:28:06.160 --> 0:28:09.639
<v Speaker 3>pretty big drop, and then it's a little lower for

0:28:09.760 --> 0:28:13.320
<v Speaker 3>older children and for adults. If you don't get infected

0:28:13.400 --> 0:28:16.360
<v Speaker 3>until you are an adult, the risk of chronic infection

0:28:16.600 --> 0:28:20.960
<v Speaker 3>is only about two to five percent, so substantially lower.

0:28:21.480 --> 0:28:24.560
<v Speaker 2>Hmm. I mean, okay, I have to ask why.

0:28:25.200 --> 0:28:29.520
<v Speaker 3>I'm glad you asked Aaron. Let's talk about it. But

0:28:29.680 --> 0:28:33.600
<v Speaker 3>first let me also say that even though the risk

0:28:33.680 --> 0:28:37.160
<v Speaker 3>of chronic infection if you get infected as an adult

0:28:37.680 --> 0:28:43.320
<v Speaker 3>is low, the chronic infection itself and the like prognosis

0:28:43.360 --> 0:28:47.120
<v Speaker 3>of a chronic infection with hepatitis B in general is

0:28:47.280 --> 0:28:51.280
<v Speaker 3>worse than, for example, the chronic infection of hepatitis C.

0:28:51.920 --> 0:28:54.640
<v Speaker 3>And if you listened to our hepatitis C episode, then

0:28:54.680 --> 0:28:58.200
<v Speaker 3>you remember hepatitis C is not a good virus, right,

0:28:59.600 --> 0:29:04.160
<v Speaker 3>But in hepatitis C, the likelihood of a chronic infection

0:29:04.360 --> 0:29:07.760
<v Speaker 3>is much higher for adults across the board. But the

0:29:07.880 --> 0:29:12.000
<v Speaker 3>rate of for example, liver cancer is very low, like

0:29:12.040 --> 0:29:16.680
<v Speaker 3>two point five percent for people who have chronic hepatitis C. Right,

0:29:16.760 --> 0:29:19.960
<v Speaker 3>But much more people who get infected as adults with

0:29:20.040 --> 0:29:22.080
<v Speaker 3>HEPSI go on to get chronic HEPSI.

0:29:22.920 --> 0:29:28.760
<v Speaker 2>That makes sense, yeah, Like, okay, in the numbers, perspective, right, But.

0:29:28.680 --> 0:29:33.920
<v Speaker 3>For hepatitis B, fifteen to forty percent of people who

0:29:34.000 --> 0:29:40.600
<v Speaker 3>have chronic infection go on to have liver cancer, hepatocellular carcinoma.

0:29:41.360 --> 0:29:42.960
<v Speaker 3>It's a huge percentage.

0:29:43.320 --> 0:29:43.720
<v Speaker 2>Yeah.

0:29:43.760 --> 0:29:49.440
<v Speaker 3>And again, ninety percent of infants who become infected go

0:29:49.560 --> 0:29:52.480
<v Speaker 3>on to have chronic infection. So that's major.

0:29:53.120 --> 0:29:56.640
<v Speaker 2>That's a really disturbingly large number, right.

0:29:57.080 --> 0:30:02.000
<v Speaker 3>Okay, So you asked why, Yeah, I did. In short,

0:30:03.600 --> 0:30:09.000
<v Speaker 3>we don't fully know. It's always my answer.

0:30:09.360 --> 0:30:11.800
<v Speaker 2>I'm going to cross stitch that onto a pillow for you.

0:30:12.720 --> 0:30:14.000
<v Speaker 3>I would love that pillow.

0:30:14.120 --> 0:30:16.320
<v Speaker 4>Oh my gosh.

0:30:16.440 --> 0:30:20.760
<v Speaker 3>Okay. But so the question of why are infants who

0:30:20.840 --> 0:30:23.840
<v Speaker 3>get infected more likely than adults who get infected to

0:30:23.920 --> 0:30:26.880
<v Speaker 3>go on to have a chronic infection. While we don't

0:30:26.960 --> 0:30:30.120
<v Speaker 3>fully know the answer, it likely has to do with

0:30:30.160 --> 0:30:33.520
<v Speaker 3>a few different factors that relate to the various phases

0:30:33.680 --> 0:30:38.520
<v Speaker 3>of this chronic infection. So, a chronic hepatitis B infection

0:30:38.720 --> 0:30:41.960
<v Speaker 3>which is defined just as the persistence of the virus

0:30:42.040 --> 0:30:45.160
<v Speaker 3>and like detection of these viral antigens for at least

0:30:45.320 --> 0:30:49.960
<v Speaker 3>six months in the bloodstream after that point, like after

0:30:49.960 --> 0:30:54.280
<v Speaker 3>that six months point, this isn't a static infection. It's

0:30:54.480 --> 0:30:59.040
<v Speaker 3>very dynamic and it progresses through several different phases that

0:30:59.120 --> 0:31:03.520
<v Speaker 3>can vary in their length and their severity. So the

0:31:03.560 --> 0:31:07.360
<v Speaker 3>first phase is often known as immune tolerance, and that's

0:31:07.440 --> 0:31:11.200
<v Speaker 3>essentially when our body doesn't really do much about this infection.

0:31:11.760 --> 0:31:14.520
<v Speaker 3>The virus is there, and one thing that it tends

0:31:14.600 --> 0:31:18.120
<v Speaker 3>to do is integrate into our genome the way that

0:31:18.720 --> 0:31:20.440
<v Speaker 3>do you remember the other virus that does that er

0:31:20.520 --> 0:31:26.120
<v Speaker 3>in HPV HPV. That's right, And as our cells replicate,

0:31:26.240 --> 0:31:29.920
<v Speaker 3>so does this virus. But in the immune tolerance phase,

0:31:30.000 --> 0:31:33.080
<v Speaker 3>it doesn't cause much in the way of damage. Then

0:31:33.120 --> 0:31:36.400
<v Speaker 3>there is the immune active phase, and in some papers

0:31:36.440 --> 0:31:39.440
<v Speaker 3>they call this the immune clearance phase, and this is

0:31:39.480 --> 0:31:43.560
<v Speaker 3>really the meat of chronic hepatitis B infection. This is

0:31:43.560 --> 0:31:47.760
<v Speaker 3>when our bodies are recognizing this virus, we are mounting

0:31:47.840 --> 0:31:52.480
<v Speaker 3>an immune response to it, and therefore we ourselves are

0:31:52.520 --> 0:31:55.720
<v Speaker 3>causing a lot of inflammation and damage to our own

0:31:55.760 --> 0:32:00.320
<v Speaker 3>liver cells. It's not the virus itself, Okay, Yeah, This

0:32:00.440 --> 0:32:03.400
<v Speaker 3>is the phase where people are more likely to be symptomatic,

0:32:03.560 --> 0:32:07.640
<v Speaker 3>like maybe have jaundice. But this is the phase where

0:32:07.680 --> 0:32:12.320
<v Speaker 3>that inflammation is causing fibrosis, which is damage to the

0:32:12.360 --> 0:32:16.360
<v Speaker 3>liver due to that inflammation. That fibrosis can eventually lead

0:32:16.400 --> 0:32:21.400
<v Speaker 3>to scarring or permanent damage cirrhosis, and that can ultimately

0:32:21.480 --> 0:32:25.240
<v Speaker 3>lead to liver cancer. And so this is the phase,

0:32:25.280 --> 0:32:28.080
<v Speaker 3>the immune active phase that the longer that somebody is

0:32:28.120 --> 0:32:31.800
<v Speaker 3>in this phase their immune system fighting the infection, the

0:32:31.840 --> 0:32:35.320
<v Speaker 3>greater their risk of cancer. Okay, but there is another

0:32:35.400 --> 0:32:38.720
<v Speaker 3>phase just to get more complicated, and that's a so

0:32:38.760 --> 0:32:42.440
<v Speaker 3>called inactive phase, wherein the virus is still there and

0:32:42.480 --> 0:32:46.120
<v Speaker 3>we've maybe made some antibodies against that virus, so we're

0:32:46.160 --> 0:32:49.520
<v Speaker 3>kind of at a standstill. But at any point, people

0:32:49.560 --> 0:32:52.800
<v Speaker 3>could still revert back to a more immune active infection,

0:32:53.200 --> 0:32:56.200
<v Speaker 3>like say if they became immuno compromised for some reason

0:32:57.240 --> 0:32:59.840
<v Speaker 3>and therefore the virus is still there and still posing

0:33:00.200 --> 0:33:01.480
<v Speaker 3>risk of cancer development.

0:33:02.080 --> 0:33:03.920
<v Speaker 2>Gotcha that makes sense.

0:33:04.480 --> 0:33:06.400
<v Speaker 3>Yeah, So I know that that was a lot and

0:33:06.440 --> 0:33:09.120
<v Speaker 3>it was really just a drive by. The immunology of

0:33:09.160 --> 0:33:12.600
<v Speaker 3>HEPBIE infection is a lot more complicated. There's a lot

0:33:12.600 --> 0:33:15.200
<v Speaker 3>more detail. But one of the things that's different among

0:33:15.280 --> 0:33:19.160
<v Speaker 3>adults who get infected versus infants is that infants tend

0:33:19.160 --> 0:33:24.040
<v Speaker 3>to have a very long immune tolerant phase, whereas adults

0:33:24.160 --> 0:33:27.840
<v Speaker 3>who have chronic hepatitis B. That is, they get infected

0:33:27.880 --> 0:33:31.800
<v Speaker 3>and aren't able to clear that infection right away, they

0:33:31.840 --> 0:33:34.920
<v Speaker 3>tend to not really have an immune tolerant phase, but

0:33:35.040 --> 0:33:42.600
<v Speaker 3>rather progress directly to that active inflammatory chronic hepatitis infection. Right, okay,

0:33:42.720 --> 0:33:45.440
<v Speaker 3>So that's a really big difference. And it's thought that

0:33:45.840 --> 0:33:51.600
<v Speaker 3>during pregnancy, viral particles or maternal antibodies or both are

0:33:51.640 --> 0:33:54.520
<v Speaker 3>passing through to the fetus, and then when that infant

0:33:54.600 --> 0:33:57.520
<v Speaker 3>is born and exposed to hepatitis B, while they're not

0:33:57.680 --> 0:34:01.560
<v Speaker 3>able to fight off that virus entire the way most

0:34:01.640 --> 0:34:06.080
<v Speaker 3>adults who are exposed can, they instead establish this relationship

0:34:06.120 --> 0:34:09.800
<v Speaker 3>of tolerance that lends itself more easily to a chronic infection.

0:34:10.680 --> 0:34:14.560
<v Speaker 2>Oh right, okay, so it's kind of like getting to

0:34:14.640 --> 0:34:17.080
<v Speaker 2>know you and like, all right, I guess we'll just

0:34:17.320 --> 0:34:20.320
<v Speaker 2>tolerate you know each other for a while, right.

0:34:20.239 --> 0:34:23.680
<v Speaker 3>But then eventually progress to the other phases of disease.

0:34:24.120 --> 0:34:24.960
<v Speaker 2>Right, okay.

0:34:25.440 --> 0:34:29.560
<v Speaker 3>Interesting, but that is generally hepatitis B virus.

0:34:30.600 --> 0:34:33.800
<v Speaker 2>So I have a question, h you mentioned that. Okay,

0:34:34.000 --> 0:34:36.840
<v Speaker 2>there are people who become infected and they cleared the virus,

0:34:36.840 --> 0:34:39.560
<v Speaker 2>they develop antibodies boom, they're in the category that you

0:34:39.600 --> 0:34:43.440
<v Speaker 2>didn't discuss the later stages on for obvious reasons, and

0:34:43.520 --> 0:34:48.279
<v Speaker 2>so these people now have a lifetime immunity to hepatitis

0:34:48.360 --> 0:34:53.239
<v Speaker 2>B virus. What about different genotypes are is there any

0:34:53.280 --> 0:34:57.640
<v Speaker 2>sort of like genotype dependent immunity where you can be

0:34:57.680 --> 0:35:00.840
<v Speaker 2>infected with one genotype and then clear that and be

0:35:00.880 --> 0:35:03.120
<v Speaker 2>exposed to another one and not clear that?

0:35:03.600 --> 0:35:08.480
<v Speaker 3>Great question, Aaron. As far as everything that I have read,

0:35:08.920 --> 0:35:14.400
<v Speaker 3>immunity to hepatitis B is immunity to hepatitis B across genotypes.

0:35:14.600 --> 0:35:18.040
<v Speaker 3>That's great news exactly. It's really great news, Aaron, because

0:35:18.040 --> 0:35:22.080
<v Speaker 3>we in fact have a vaccine for hepatitis B. It

0:35:22.160 --> 0:35:27.640
<v Speaker 3>is a recombinant vaccine that contains only the surface antigen

0:35:28.200 --> 0:35:32.480
<v Speaker 3>of hepatitis B, and that is what we make antibodies too.

0:35:32.920 --> 0:35:37.719
<v Speaker 4>Have a follow up question, Okay, if someone is chronically

0:35:37.760 --> 0:35:42.360
<v Speaker 4>infected with one genotype of hepatitis B, can they become

0:35:42.520 --> 0:35:45.360
<v Speaker 4>infected with another genotype of hepatitis B?

0:35:46.080 --> 0:35:49.319
<v Speaker 3>Not as far as I know, But do you know what?

0:35:49.360 --> 0:35:51.120
<v Speaker 3>They can become infected.

0:35:50.719 --> 0:35:52.200
<v Speaker 2>With hepatitis D.

0:35:52.760 --> 0:35:56.720
<v Speaker 3>Hepatitis D. Thanks for the little intro there.

0:35:57.600 --> 0:35:58.800
<v Speaker 2>You're welcome. You're welcome.

0:35:59.000 --> 0:36:03.000
<v Speaker 3>I want to just very we briefly mention hepatitis D

0:36:03.120 --> 0:36:05.239
<v Speaker 3>because I don't think that we would ever do a

0:36:05.280 --> 0:36:07.480
<v Speaker 3>full episode on it. I don't know, maybe I'm wrong,

0:36:08.440 --> 0:36:14.239
<v Speaker 3>but delta hepatitis virus or hepatitis delta HEPD, it's a

0:36:14.320 --> 0:36:19.840
<v Speaker 3>fascinating virus. This virus belongs to its entire own viral

0:36:19.920 --> 0:36:23.680
<v Speaker 3>genus that doesn't have an actual family that it falls within.

0:36:24.160 --> 0:36:27.120
<v Speaker 3>And some people say it's not even really a virus,

0:36:27.200 --> 0:36:31.080
<v Speaker 3>it's like something else entirely. It's a subviral agent.

0:36:32.719 --> 0:36:36.440
<v Speaker 2>Whoa what it's like a virus of a virus.

0:36:36.520 --> 0:36:43.560
<v Speaker 3>It's kind of so. Hepatitis D has an RNA genome,

0:36:44.200 --> 0:36:48.080
<v Speaker 3>and it can replicate on its own inside of our

0:36:48.160 --> 0:36:50.960
<v Speaker 3>cells and when it infects us, and it does infect

0:36:51.000 --> 0:36:56.440
<v Speaker 3>our liver cells, but it can't actually infect our cells

0:36:56.719 --> 0:37:01.959
<v Speaker 3>by itself. It relies on the surface pines of hepatitis

0:37:02.120 --> 0:37:06.479
<v Speaker 3>B virus in order to get into our cells and

0:37:07.040 --> 0:37:11.120
<v Speaker 3>in order to be released from our cells. So hepatitis

0:37:11.200 --> 0:37:14.439
<v Speaker 3>D is a virus that can only infect someone who

0:37:14.560 --> 0:37:18.560
<v Speaker 3>has a chronic or acute hepatitis B infection.

0:37:20.600 --> 0:37:22.960
<v Speaker 2>I'm really regretting right now not reading more about the

0:37:23.000 --> 0:37:27.359
<v Speaker 2>evolutionary origins of hepatitis D because.

0:37:27.520 --> 0:37:31.640
<v Speaker 3>On Earth, maybe it does deserve its whole own episode. Yeah,

0:37:32.440 --> 0:37:34.719
<v Speaker 3>that's that's literally all I have to say about it.

0:37:34.840 --> 0:37:37.080
<v Speaker 3>But it is very very interesting.

0:37:38.000 --> 0:37:42.200
<v Speaker 2>Okay, So what about besides the vaccine? What about treatments?

0:37:42.239 --> 0:37:45.520
<v Speaker 2>Are there anti viral treatments for hepatitis B virus or

0:37:45.719 --> 0:37:47.680
<v Speaker 2>maybe B and hept combined.

0:37:48.000 --> 0:37:52.000
<v Speaker 3>Yes, for hepatitis B there are, So there's a number

0:37:52.080 --> 0:37:56.160
<v Speaker 3>of different treatments that we have. Actually none of them

0:37:56.280 --> 0:37:59.600
<v Speaker 3>can cure hepatitis B. They are all used to sort

0:37:59.600 --> 0:38:02.360
<v Speaker 3>of man and to try and reduce the rate of

0:38:02.440 --> 0:38:07.719
<v Speaker 3>inflammation and complications. But pigilated interferon, which I think we

0:38:07.800 --> 0:38:12.600
<v Speaker 3>talked about in our hepsy episode, possibly, but that's basically

0:38:12.719 --> 0:38:15.360
<v Speaker 3>like an immune modulator. You can think of it as

0:38:16.360 --> 0:38:18.879
<v Speaker 3>that can be used and has been used to treat

0:38:18.880 --> 0:38:22.680
<v Speaker 3>hepatitis B. But there are also a number of anti

0:38:22.800 --> 0:38:26.720
<v Speaker 3>virals that in many cases are used to treat HIV

0:38:27.040 --> 0:38:29.600
<v Speaker 3>or we're used to treat HIV and are now used

0:38:29.600 --> 0:38:34.120
<v Speaker 3>to treat he B. So yes, there are Again, none

0:38:34.160 --> 0:38:36.640
<v Speaker 3>of them actually clear the infection, but they all just

0:38:36.680 --> 0:38:39.840
<v Speaker 3>sort of help to manage it. Okay, And what's really

0:38:39.920 --> 0:38:44.200
<v Speaker 3>important about all of these is that because all of

0:38:44.200 --> 0:38:49.360
<v Speaker 3>those different states immune tolerance, immune active, inactive, these different

0:38:49.480 --> 0:38:54.520
<v Speaker 3>phases of infection really very person to person and how

0:38:54.600 --> 0:38:58.680
<v Speaker 3>severe someone's symptoms might be, like it really varies. So

0:38:59.600 --> 0:39:04.120
<v Speaker 3>just because someone has an infection with chronic hepatitis B

0:39:04.880 --> 0:39:07.280
<v Speaker 3>doesn't necessarily mean that they have to be on treatment

0:39:07.719 --> 0:39:10.400
<v Speaker 3>if they're in a phase that isn't directly causing damage.

0:39:10.480 --> 0:39:10.759
<v Speaker 3>Does that?

0:39:10.800 --> 0:39:12.960
<v Speaker 2>Okay? Yeah, that's interesting.

0:39:12.640 --> 0:39:15.600
<v Speaker 3>At least as of now, because the treatments that we

0:39:15.680 --> 0:39:17.640
<v Speaker 3>do have are not without side effects, and in a

0:39:17.640 --> 0:39:19.680
<v Speaker 3>lot of cases they have quite a lot of side effects,

0:39:21.000 --> 0:39:24.040
<v Speaker 3>so it requires a lot of careful monitoring and everything,

0:39:24.080 --> 0:39:26.640
<v Speaker 3>which makes it a lot harder to do. Quite honestly,

0:39:27.320 --> 0:39:30.160
<v Speaker 3>there's so much here about this virus that I know,

0:39:31.400 --> 0:39:35.600
<v Speaker 3>so speaking of so much about this virus arin like

0:39:35.960 --> 0:39:37.960
<v Speaker 3>what where did it come from? What the heck?

0:39:39.360 --> 0:39:41.840
<v Speaker 2>I will do my best to answer those questions, But

0:39:41.960 --> 0:40:19.239
<v Speaker 2>let's take a quick break first, all right, the story

0:40:19.360 --> 0:40:23.080
<v Speaker 2>of hepatitis B. I feel like in the last couple

0:40:23.120 --> 0:40:27.040
<v Speaker 2>of episodes, I've maybe deviated a bit from the normal

0:40:27.200 --> 0:40:31.399
<v Speaker 2>history overview that I usually give. But don't worry, I'm

0:40:31.440 --> 0:40:35.600
<v Speaker 2>going back to my roots for this one. I'm going

0:40:35.680 --> 0:40:38.320
<v Speaker 2>to start with a bit of evolutionary history, mix in

0:40:38.400 --> 0:40:42.920
<v Speaker 2>some early accounts of infectious hepatitis, then the fascinating story

0:40:42.960 --> 0:40:46.479
<v Speaker 2>of its identification, and then finally getting us to where

0:40:46.480 --> 0:40:47.240
<v Speaker 2>we are today.

0:40:48.000 --> 0:40:51.600
<v Speaker 3>The usual, the usually, I love it, but usual.

0:40:51.320 --> 0:40:55.279
<v Speaker 2>Doesn't mean boring or straightforward, especially in the case of

0:40:55.400 --> 0:41:00.920
<v Speaker 2>hepatitis B. So beginning at the beginning, where does the

0:41:00.960 --> 0:41:05.120
<v Speaker 2>hepatitis B virus come from? It turns out that the

0:41:05.160 --> 0:41:08.600
<v Speaker 2>answer to that question has been a moving target for

0:41:08.719 --> 0:41:13.399
<v Speaker 2>a number of years, with new hypotheses introduced or old

0:41:13.480 --> 0:41:17.959
<v Speaker 2>hypotheses overturned or tweaked to fit new findings. As more

0:41:17.960 --> 0:41:21.359
<v Speaker 2>about the evolutionary history of this virus has come to light,

0:41:22.400 --> 0:41:25.640
<v Speaker 2>and this should come as no surprise really, considering how

0:41:25.760 --> 0:41:29.839
<v Speaker 2>widespread this virus is, how many genotypes there seem to be,

0:41:30.440 --> 0:41:35.279
<v Speaker 2>how the virus can undergo recombination, the confusion about its

0:41:35.480 --> 0:41:39.600
<v Speaker 2>partially double stranded DNA, and how we don't really know

0:41:39.760 --> 0:41:44.680
<v Speaker 2>exactly maybe the rate of evolution or mutation. There's been

0:41:44.800 --> 0:41:47.680
<v Speaker 2>a lot of work on this I was happily surprised

0:41:47.719 --> 0:41:51.080
<v Speaker 2>to find, especially recently, and so I'm going to try

0:41:51.080 --> 0:41:53.560
<v Speaker 2>to bring us up to speed on what the current

0:41:53.640 --> 0:41:57.480
<v Speaker 2>consensus is relying mostly on two papers that came out

0:41:57.480 --> 0:42:01.000
<v Speaker 2>in twenty twenty one about the origins evolution of the

0:42:01.000 --> 0:42:05.360
<v Speaker 2>hepatitis B virus, one by Lochernini at all and the

0:42:05.400 --> 0:42:09.759
<v Speaker 2>other Bycolture at All. Like you said, Erin, the hepatitis

0:42:09.760 --> 0:42:14.000
<v Speaker 2>B virus belongs to the Hepadinaviidae family, and in the

0:42:14.080 --> 0:42:18.400
<v Speaker 2>years after the hepatitis B virus was first identified, researchers

0:42:18.440 --> 0:42:23.759
<v Speaker 2>found viruses belonging to that family that infected birds, fish, reptiles,

0:42:23.800 --> 0:42:28.920
<v Speaker 2>and amphibians, other mammals, non human primates, et cetera. Basically,

0:42:29.080 --> 0:42:31.680
<v Speaker 2>this is a lot bigger and a lot older of

0:42:31.719 --> 0:42:35.239
<v Speaker 2>a virus family than we thought with there. And there

0:42:35.239 --> 0:42:38.920
<v Speaker 2>are some estimates that it originated around eighty two million

0:42:39.000 --> 0:42:46.040
<v Speaker 2>years ago. WHOA, So, like this thing was infecting birds essentially, Yeah,

0:42:47.040 --> 0:42:50.960
<v Speaker 2>back when birds and dinosaurs were the same thing. Yeah,

0:42:51.640 --> 0:42:55.320
<v Speaker 2>I hope that that's probably not accurate, but you know

0:42:55.360 --> 0:42:58.200
<v Speaker 2>what I mean, eighty two million years let's stick with that. Yeah,

0:42:58.239 --> 0:43:01.319
<v Speaker 2>So from eighty two million years years ago, how did

0:43:01.360 --> 0:43:05.880
<v Speaker 2>it get into modern humans? And on that there seems

0:43:05.920 --> 0:43:10.160
<v Speaker 2>to be some debate, surprise, surprise. For a long time

0:43:10.280 --> 0:43:14.280
<v Speaker 2>it was thought that hepatitis B virus originated in Africa,

0:43:14.800 --> 0:43:17.640
<v Speaker 2>or for a while it was thought maybe the Americas,

0:43:18.239 --> 0:43:21.880
<v Speaker 2>and then it spilled over into humans, possibly from like

0:43:21.920 --> 0:43:25.960
<v Speaker 2>a non human primate, and then dispersed. Maybe it was

0:43:26.000 --> 0:43:30.359
<v Speaker 2>dispersing out of Africa following prehistoric patterns of human migrations,

0:43:31.320 --> 0:43:36.080
<v Speaker 2>but more recently that assumption has been questioned. So one

0:43:36.120 --> 0:43:40.000
<v Speaker 2>of the studies published in twenty twenty one used hepatitis

0:43:40.040 --> 0:43:43.440
<v Speaker 2>B virus detected in skeletal remains of one hundred and

0:43:43.440 --> 0:43:48.120
<v Speaker 2>thirty seven individuals found in Eurasia and the Americas and

0:43:48.200 --> 0:43:52.040
<v Speaker 2>dating between ten thousand, five hundred years ago and four

0:43:52.120 --> 0:43:58.400
<v Speaker 2>hundred years ago. What that's some old viral DNA.

0:43:58.880 --> 0:44:01.520
<v Speaker 3>I just love it when you find things like this, Aaron,

0:44:02.040 --> 0:44:02.680
<v Speaker 3>I know.

0:44:02.760 --> 0:44:06.400
<v Speaker 2>It's this paper was really interesting. It also had the

0:44:06.400 --> 0:44:09.040
<v Speaker 2>most authors of any paper I've ever seen. I think

0:44:09.040 --> 0:44:10.520
<v Speaker 2>it was one hundred and seventy something.

0:44:10.640 --> 0:44:14.480
<v Speaker 3>Oh my goodness, that's more than like the whole human

0:44:14.520 --> 0:44:15.360
<v Speaker 3>genome paper.

0:44:18.040 --> 0:44:20.040
<v Speaker 2>But I mean it makes sense because I'm assuming that

0:44:20.040 --> 0:44:23.680
<v Speaker 2>there was a lot of collaboration across many different universities

0:44:23.719 --> 0:44:29.080
<v Speaker 2>with all of these remains skeletal remains, So okay. Anyway,

0:44:29.239 --> 0:44:32.960
<v Speaker 2>So what this paper, using all of these old skeletal

0:44:33.000 --> 0:44:37.520
<v Speaker 2>remains with hepatitis B virus did is that they wanted

0:44:37.520 --> 0:44:42.280
<v Speaker 2>to reconstruct the evolutionary history and dispersion of the virus.

0:44:43.000 --> 0:44:45.800
<v Speaker 2>And what they propose is that the most recent common

0:44:45.840 --> 0:44:50.120
<v Speaker 2>ancestor of the hepatitis B virus dates back to around

0:44:50.160 --> 0:44:53.600
<v Speaker 2>twelve thousand to sixteen thousand years ago, which is more

0:44:53.640 --> 0:44:57.920
<v Speaker 2>recent actually than was previously thought. And it places that

0:44:58.000 --> 0:45:01.680
<v Speaker 2>most recent common ancestor in your Asia, where over the

0:45:01.719 --> 0:45:06.080
<v Speaker 2>next hundreds and thousands of years it spread across Eurasia,

0:45:06.120 --> 0:45:11.440
<v Speaker 2>into Africa, through Europe and to the Americas. It seems

0:45:11.520 --> 0:45:14.840
<v Speaker 2>like the emergence of the hepatitis B virus and some

0:45:15.080 --> 0:45:19.160
<v Speaker 2>of it spread happened to before the Neolithic Revolution, which

0:45:19.239 --> 0:45:22.120
<v Speaker 2>is when people began settling in larger groups and farming

0:45:22.160 --> 0:45:24.840
<v Speaker 2>and so on. And if you think about it, this

0:45:24.960 --> 0:45:28.839
<v Speaker 2>completely makes sense because what are some of the transmission

0:45:28.920 --> 0:45:33.920
<v Speaker 2>characteristics that hepatitis BEE has. Right, people can be carriers.

0:45:34.239 --> 0:45:36.640
<v Speaker 2>It can be transmitted to a baby at birth. It

0:45:36.680 --> 0:45:40.000
<v Speaker 2>can be spread during sexual contact or through blood so

0:45:40.200 --> 0:45:44.480
<v Speaker 2>like violent interactions or tattooing. Even there are many different

0:45:44.520 --> 0:45:48.960
<v Speaker 2>ways that this virus can be transmitted, and the fact

0:45:49.040 --> 0:45:51.719
<v Speaker 2>that there are people who can carry it for long

0:45:51.760 --> 0:45:55.280
<v Speaker 2>periods of time means that it doesn't need this critical

0:45:55.360 --> 0:46:00.000
<v Speaker 2>population size in order to spread or persist in a pupeat.

0:46:01.719 --> 0:46:03.879
<v Speaker 2>So in that way, it's a lot like a couple

0:46:03.960 --> 0:46:06.680
<v Speaker 2>of the other viruses that we've talked about before, like

0:46:06.800 --> 0:46:11.760
<v Speaker 2>the herpee simplex virus or chicken pox virus. But once

0:46:11.840 --> 0:46:15.600
<v Speaker 2>people began settling in larger groups around seven thousand to

0:46:15.680 --> 0:46:19.759
<v Speaker 2>eight thousand years ago, that meant, of course, more opportunities

0:46:19.760 --> 0:46:23.600
<v Speaker 2>for transmission, which led to an increase in the diversity

0:46:23.640 --> 0:46:27.560
<v Speaker 2>of hepatitis B virus strains and the emergence of multiple

0:46:27.640 --> 0:46:31.400
<v Speaker 2>genotypes or lineages. I'm not going to go into a

0:46:31.400 --> 0:46:34.160
<v Speaker 2>ton of detail about this, but the paper that I

0:46:34.239 --> 0:46:38.080
<v Speaker 2>keep mentioning by Kosher at all actually trace the kind

0:46:38.120 --> 0:46:43.040
<v Speaker 2>of like rise and fall of different hepatitis B virus lineages.

0:46:43.760 --> 0:46:47.279
<v Speaker 2>So one, for instance, seemed to be the prevailing lineage

0:46:47.280 --> 0:46:50.960
<v Speaker 2>in western Eurasia for like four thousand years, but then

0:46:51.080 --> 0:46:55.279
<v Speaker 2>it disappeared around thirty three hundred years ago. It just

0:46:55.600 --> 0:47:00.719
<v Speaker 2>went almost extinct. No idea why, Maybe sampling bias, maybe

0:47:00.719 --> 0:47:03.719
<v Speaker 2>a reduction in human population that kind of like bottlenecked

0:47:03.880 --> 0:47:07.680
<v Speaker 2>or eliminated it, or maybe it was like inter genotype dynamics.

0:47:07.719 --> 0:47:13.759
<v Speaker 2>Who knows? So interesting eron, I find this so fascinating,

0:47:14.320 --> 0:47:18.719
<v Speaker 2>and this pattern of genotypes going extinct and shifts in

0:47:18.760 --> 0:47:21.680
<v Speaker 2>the predominant genotype, it still happens today, and we don't

0:47:21.680 --> 0:47:24.680
<v Speaker 2>know for sure, but maybe it's partially due to the

0:47:24.719 --> 0:47:28.120
<v Speaker 2>fact that some genotypes may be associated with certain transmission

0:47:28.200 --> 0:47:32.480
<v Speaker 2>routes I've seen, and maybe some of the genotypes vary

0:47:32.560 --> 0:47:36.239
<v Speaker 2>in their ability to cause severe disease or in their

0:47:36.280 --> 0:47:40.200
<v Speaker 2>ability to cause this persistent carrier state. And so that's

0:47:40.320 --> 0:47:43.960
<v Speaker 2>I think why it's really important to understand the origins

0:47:44.040 --> 0:47:47.640
<v Speaker 2>and the evolutionary history of a virus like the hepatitis

0:47:47.719 --> 0:47:50.719
<v Speaker 2>B virus. It can tell us, in part why we

0:47:50.760 --> 0:47:54.000
<v Speaker 2>see some of the epidemiological patterns that we see today,

0:47:54.760 --> 0:47:57.719
<v Speaker 2>and it might be helpful for predicting what we could

0:47:57.719 --> 0:48:02.080
<v Speaker 2>expect to see in the future. Okay, So we have

0:48:02.200 --> 0:48:05.720
<v Speaker 2>this virus that has ancient roots and that had reached

0:48:05.760 --> 0:48:09.279
<v Speaker 2>a global distribution a long time before the present day.

0:48:10.120 --> 0:48:13.680
<v Speaker 2>And I already mentioned that evidence of hepatitis B infection

0:48:13.880 --> 0:48:17.680
<v Speaker 2>has been found in ancient human remains dating back thousands

0:48:17.719 --> 0:48:20.839
<v Speaker 2>of thousands of years as well as just a couple

0:48:20.960 --> 0:48:24.520
<v Speaker 2>thousand years as well as more recent So basically it's

0:48:24.600 --> 0:48:28.759
<v Speaker 2>kind of like persisted in human populations for all of

0:48:28.800 --> 0:48:34.200
<v Speaker 2>that time. But were the people who were around back

0:48:34.239 --> 0:48:36.880
<v Speaker 2>then aware of this? Did they have any idea?

0:48:37.320 --> 0:48:38.239
<v Speaker 3>Were they did?

0:48:38.280 --> 0:48:44.520
<v Speaker 2>They? Well? Probably in a sense. So jaundice, which can

0:48:44.560 --> 0:48:48.160
<v Speaker 2>be caused by many different things, including the hepatitis B virus,

0:48:48.360 --> 0:48:51.880
<v Speaker 2>has long been recognized and described an ancient medical text.

0:48:52.719 --> 0:48:56.320
<v Speaker 2>I'll toss in the Hippocratic texts from around four hundred

0:48:56.360 --> 0:48:59.279
<v Speaker 2>BCE because it's an episode of this podcast will Kill

0:48:59.360 --> 0:49:05.800
<v Speaker 2>You and and outbreaks of jaundice were also written about.

0:49:06.200 --> 0:49:08.600
<v Speaker 2>So one paper I read suggested that there was a

0:49:08.640 --> 0:49:12.360
<v Speaker 2>description of what was likely infectious hepatitis dating back to

0:49:12.400 --> 0:49:16.680
<v Speaker 2>the eighth century CE, and it was sometimes called campaign

0:49:16.840 --> 0:49:21.480
<v Speaker 2>jaundice because it seemed prevalent during times of war. Surprise, surprise,

0:49:22.960 --> 0:49:26.480
<v Speaker 2>But switching from talking about the evolutionary history of the

0:49:26.480 --> 0:49:30.840
<v Speaker 2>hepatitis B virus to the written human history part, it's

0:49:30.920 --> 0:49:37.680
<v Speaker 2>tricky because of the existence of other hepatitis viruses hepatiti hepatid.

0:49:39.080 --> 0:49:43.080
<v Speaker 2>We can test human remains for hepatitis B virus, specifically

0:49:43.480 --> 0:49:46.800
<v Speaker 2>but we can't always know which hepatitis virus was causing

0:49:46.840 --> 0:49:51.279
<v Speaker 2>whatever outbreak that was being described. How likely was it

0:49:51.360 --> 0:49:55.680
<v Speaker 2>that it was hepatitis B in terms of outbreaks, I

0:49:55.719 --> 0:49:59.040
<v Speaker 2>would guess actually that the hepatitis A virus which is

0:49:59.080 --> 0:50:03.640
<v Speaker 2>transmitted f may have been the culprit more often than not,

0:50:03.880 --> 0:50:08.520
<v Speaker 2>especially in crowded or unsanitary conditions like you know, war.

0:50:08.760 --> 0:50:13.880
<v Speaker 3>Yeah, and especially in any that were like acute infections.

0:50:14.560 --> 0:50:19.480
<v Speaker 2>Yes, like mm hm, exactly, yeah. But it's certainly possible

0:50:19.520 --> 0:50:24.640
<v Speaker 2>that hepatitis BE and other hepatitis viruses transmitted through blood

0:50:24.840 --> 0:50:29.759
<v Speaker 2>or bodily fluids caused outbreaks, especially as the use and

0:50:29.880 --> 0:50:34.200
<v Speaker 2>reuse of needles became more popular around the middle of

0:50:34.239 --> 0:50:38.680
<v Speaker 2>the nineteenth century. So let's fast forward to then the

0:50:38.760 --> 0:50:42.640
<v Speaker 2>last decades of the eighteen hundreds. So this is like

0:50:42.880 --> 0:50:46.640
<v Speaker 2>after the development of germ theory and after the introduction

0:50:46.800 --> 0:50:52.040
<v Speaker 2>of some injectable vaccines. In eighteen eighty five, an epidemic

0:50:52.080 --> 0:50:57.719
<v Speaker 2>of jaundice followed a smallpox vaccination campaign among shipworkers in Bremen, Germany,

0:50:58.360 --> 0:51:01.480
<v Speaker 2>which led to what seems like an early indication that

0:51:01.520 --> 0:51:05.719
<v Speaker 2>hepatitis outbreaks could be caused by the reuse of needles,

0:51:05.880 --> 0:51:11.000
<v Speaker 2>or because this particular vaccine used like human serum as

0:51:11.040 --> 0:51:16.640
<v Speaker 2>a stabilizing agent through like blood products. But the link

0:51:16.840 --> 0:51:20.959
<v Speaker 2>between the administration of this vaccine and the resulting hepatitis

0:51:21.000 --> 0:51:26.319
<v Speaker 2>outbreak it wasn't recognized for decades, possibly obscured by this

0:51:26.520 --> 0:51:31.200
<v Speaker 2>long standing recognition that epidemics of hepatitis or jaundice were

0:51:31.239 --> 0:51:35.440
<v Speaker 2>also known to frequently happen in overcrowded, unsanitary areas, so

0:51:35.480 --> 0:51:39.399
<v Speaker 2>it was more difficult to pinpoint the vaccine itself as

0:51:39.640 --> 0:51:42.319
<v Speaker 2>the cause, rather than like, oh, well, maybe they all

0:51:42.360 --> 0:51:46.520
<v Speaker 2>went to the same watering hole, to the same to

0:51:46.600 --> 0:51:49.920
<v Speaker 2>the same watering hole where they all got hepatitis.

0:51:50.080 --> 0:51:51.239
<v Speaker 3>Yeah.

0:51:51.440 --> 0:51:55.520
<v Speaker 2>Yeah. But as blood transfusions increased and the practice of

0:51:55.560 --> 0:51:59.799
<v Speaker 2>reusing needles persisted, there was this growing suspicion that an

0:51:59.800 --> 0:52:03.600
<v Speaker 2>in infectious hepatitis might also be carried in the blood

0:52:03.719 --> 0:52:09.160
<v Speaker 2>or blood products. See our hepatitis c episode for more

0:52:09.400 --> 0:52:12.320
<v Speaker 2>on the history of blood transfusions and the blood typing

0:52:12.360 --> 0:52:18.880
<v Speaker 2>system and so on. The differentiation of two different hepatitises,

0:52:19.600 --> 0:52:23.800
<v Speaker 2>one called transfusion hepatitis and the other one being called

0:52:24.000 --> 0:52:28.000
<v Speaker 2>infectious or food or waterborne hepatitis. This was finally made

0:52:28.040 --> 0:52:32.200
<v Speaker 2>in the early nineteen forties. During World War Two, hundreds

0:52:32.239 --> 0:52:36.920
<v Speaker 2>of thousands of US Army personnel received the yellow fever vaccine, which,

0:52:37.360 --> 0:52:40.840
<v Speaker 2>like the eighteen eighty five smallpox vaccine, had human serum

0:52:41.000 --> 0:52:45.200
<v Speaker 2>as an ingredient. Obviously that's no longer done for safety

0:52:45.280 --> 0:52:51.960
<v Speaker 2>reasons needed to maybe clarify that. But after receiving this vaccine,

0:52:52.200 --> 0:52:57.439
<v Speaker 2>fifty thousand people came down with hepatitis, although those were

0:52:57.520 --> 0:53:01.840
<v Speaker 2>just the clinically recognized cases. Later estimates put the total

0:53:01.880 --> 0:53:06.560
<v Speaker 2>figure of hepatitis infections resulting from this vaccination campaign at

0:53:06.600 --> 0:53:09.520
<v Speaker 2>around three hundred and thirty thousand.

0:53:10.160 --> 0:53:14.680
<v Speaker 3>Oh dear, okay, oh gosh, Oh dear, okay.

0:53:14.320 --> 0:53:18.320
<v Speaker 2>It's a lot, it's a lot. Yeah. And there was

0:53:18.360 --> 0:53:21.799
<v Speaker 2>a British doctor named f. O. Mcallum who had been

0:53:21.840 --> 0:53:25.520
<v Speaker 2>involved in the development and administration of this vaccine, and

0:53:25.560 --> 0:53:29.560
<v Speaker 2>he hypothesized that it might have been transmitted by reusing

0:53:29.640 --> 0:53:33.319
<v Speaker 2>syringes or carried in the vaccine itself. And he thought

0:53:33.360 --> 0:53:37.520
<v Speaker 2>that this hepatitis represented a blood born infection, separate from

0:53:37.560 --> 0:53:43.200
<v Speaker 2>the previously recognized food and waterborn hepatitis. He proposed that

0:53:43.280 --> 0:53:47.560
<v Speaker 2>they be called hepatitis A and B, and that they

0:53:47.640 --> 0:53:50.040
<v Speaker 2>may represent different viruses.

0:53:50.520 --> 0:53:52.120
<v Speaker 3>So this is how it begins.

0:53:52.600 --> 0:53:56.680
<v Speaker 2>This is how it begins because at the time it

0:53:56.719 --> 0:54:00.640
<v Speaker 2>was like not known whether it was the virus or

0:54:00.680 --> 0:54:02.880
<v Speaker 2>different viruses, and so it was more in like the

0:54:03.000 --> 0:54:07.960
<v Speaker 2>clinical picture of it in a way. Because after this designation,

0:54:08.040 --> 0:54:11.319
<v Speaker 2>after this recognition that like, hey, this might be transmitted

0:54:11.360 --> 0:54:14.480
<v Speaker 2>through blood products and not just through like food and

0:54:14.560 --> 0:54:20.200
<v Speaker 2>water or whatever, other researchers began to describe differences in

0:54:20.280 --> 0:54:24.600
<v Speaker 2>the way that these two hepatida looked clinically, and to

0:54:24.680 --> 0:54:27.800
<v Speaker 2>kind of keep an eye out more on the different

0:54:27.880 --> 0:54:28.919
<v Speaker 2>roots of transmission.

0:54:29.560 --> 0:54:32.520
<v Speaker 3>Once you have it more like hey, there are two

0:54:32.520 --> 0:54:34.640
<v Speaker 3>different things here, then you start to notice more of

0:54:34.640 --> 0:54:35.320
<v Speaker 3>the differences.

0:54:35.719 --> 0:54:39.719
<v Speaker 2>Right. Once you create those like columns, then it's then

0:54:39.719 --> 0:54:42.480
<v Speaker 2>it becomes much easier to add to the listen in.

0:54:44.960 --> 0:54:47.840
<v Speaker 2>But just because people now knew that hepatitis could be

0:54:47.880 --> 0:54:52.360
<v Speaker 2>transmitted by reusing needles or via blood products, that didn't

0:54:52.400 --> 0:54:56.400
<v Speaker 2>mean they could stop it from happening. Liked I talked

0:54:56.400 --> 0:55:00.280
<v Speaker 2>about in our hepatitis see episode. Blood transfusion or blood

0:55:00.280 --> 0:55:05.080
<v Speaker 2>product technology vastly outpaced our ability to identify many blood

0:55:05.120 --> 0:55:09.560
<v Speaker 2>borne pathogens, especially viruses, which led to blood products that

0:55:09.600 --> 0:55:14.120
<v Speaker 2>were unknowingly contaminated, and often it was seen as this

0:55:14.280 --> 0:55:18.200
<v Speaker 2>kind of situation where it was like, well, we don't

0:55:18.200 --> 0:55:21.080
<v Speaker 2>know whether or not this batch of blood has hepatitis

0:55:21.160 --> 0:55:24.880
<v Speaker 2>virus in it, but you can either receive the blood

0:55:24.960 --> 0:55:28.520
<v Speaker 2>and possibly get hepatitis down the line, or not take

0:55:28.560 --> 0:55:31.960
<v Speaker 2>the blood and die of blood loss immediately. So there

0:55:32.040 --> 0:55:36.959
<v Speaker 2>was like no choice. Sometimes there was no option. That's

0:55:37.000 --> 0:55:39.880
<v Speaker 2>not to say that people weren't working on finding a

0:55:39.880 --> 0:55:42.319
<v Speaker 2>way to test the blood supply and identify what was

0:55:42.360 --> 0:55:46.160
<v Speaker 2>causing the hepatitis. If anything, it was that feeling of

0:55:46.320 --> 0:55:49.800
<v Speaker 2>being powerless to protect people from this disease that created

0:55:49.800 --> 0:55:53.239
<v Speaker 2>a sense of urgency in finding out what the hepatitis

0:55:53.280 --> 0:55:56.120
<v Speaker 2>bee agent was so that they could detect it in

0:55:56.200 --> 0:56:00.200
<v Speaker 2>blood products. But despite a ton of people work looking

0:56:00.280 --> 0:56:04.840
<v Speaker 2>on this, progress kind of stalled in the nineteen fifties

0:56:04.920 --> 0:56:09.360
<v Speaker 2>and early nineteen sixties. And I think it stalled partially

0:56:09.400 --> 0:56:13.120
<v Speaker 2>because this was a time when virology was kind of

0:56:13.160 --> 0:56:16.160
<v Speaker 2>in its infancy as a field, and the technology that

0:56:16.200 --> 0:56:20.320
<v Speaker 2>would allow for genetic testing or sequencing was still decades away.

0:56:20.920 --> 0:56:24.960
<v Speaker 3>I'm sorry, I just I had I don't know how

0:56:25.080 --> 0:56:30.000
<v Speaker 3>I didn't know that it was so recent. I know,

0:56:30.520 --> 0:56:35.480
<v Speaker 3>like nineteen fifties, nineteen sixties, that's not a long time ago.

0:56:36.160 --> 0:56:42.120
<v Speaker 2>It is. All of the hepatitis viruses are like have

0:56:42.640 --> 0:56:48.480
<v Speaker 2>very recent identification dates, but have been recognized for decades

0:56:48.520 --> 0:56:51.640
<v Speaker 2>before that. And it's just sort of this like constantly

0:56:51.760 --> 0:56:54.839
<v Speaker 2>unfolding tragedy where you're just like you see it, and

0:56:54.880 --> 0:56:57.040
<v Speaker 2>you're like and they know, Like the people who were

0:56:57.040 --> 0:56:59.480
<v Speaker 2>there at the time are like, I can't, Like, this

0:56:59.600 --> 0:57:02.120
<v Speaker 2>might have hepatitis virus in it, but I can't do

0:57:02.200 --> 0:57:03.080
<v Speaker 2>anything about it.

0:57:03.160 --> 0:57:06.759
<v Speaker 3>Right, But I don't but I don't know it. I

0:57:06.760 --> 0:57:08.200
<v Speaker 3>am like, I know it, but I.

0:57:08.120 --> 0:57:12.360
<v Speaker 2>Can't know it. Mm hm. And we can also blame

0:57:12.480 --> 0:57:16.320
<v Speaker 2>the virus itself, because this isn't to say that virology

0:57:16.360 --> 0:57:19.560
<v Speaker 2>research on all fields on all viruses had stopped or

0:57:19.600 --> 0:57:23.000
<v Speaker 2>stalled by the early nineteen fifties or sixties, because some

0:57:23.360 --> 0:57:26.600
<v Speaker 2>were easier to work with in a lab setting than others. Yeah,

0:57:26.600 --> 0:57:29.880
<v Speaker 2>and hepatitis B virus doesn't really lend itself very well

0:57:29.920 --> 0:57:33.160
<v Speaker 2>to culturing in a lab setting, and so it was

0:57:33.320 --> 0:57:36.280
<v Speaker 2>just more difficult. And especially if you don't know even

0:57:36.360 --> 0:57:38.360
<v Speaker 2>what you're looking for, how do you know that you're

0:57:38.400 --> 0:57:39.560
<v Speaker 2>on the right track at all?

0:57:40.080 --> 0:57:43.320
<v Speaker 3>Yeah, and it's a weird virus. We already said that, Yeah,

0:57:43.400 --> 0:57:44.680
<v Speaker 3>it's a weird, very weird.

0:57:45.600 --> 0:57:48.240
<v Speaker 2>And at the time it wasn't People were using the

0:57:48.360 --> 0:57:51.960
<v Speaker 2>term virus, but it wasn't known for sure whether it

0:57:52.160 --> 0:57:56.439
<v Speaker 2>was a virus or something else. It was like known

0:57:56.520 --> 0:58:00.160
<v Speaker 2>to be a virus in concept, but without physical proof.

0:58:01.320 --> 0:58:04.600
<v Speaker 2>But by the end of the nineteen sixties that would change,

0:58:05.400 --> 0:58:09.200
<v Speaker 2>and the team that led to the breakthrough identification of

0:58:09.240 --> 0:58:13.240
<v Speaker 2>the hepatitis B virus would not have been on anyone's

0:58:13.640 --> 0:58:16.800
<v Speaker 2>short or even long list of people that were likely

0:58:16.840 --> 0:58:17.720
<v Speaker 2>to have done the job.

0:58:18.600 --> 0:58:19.600
<v Speaker 3>Why who was it?

0:58:21.040 --> 0:58:25.520
<v Speaker 2>Okay, I'll get there, But before we get into the

0:58:25.800 --> 0:58:29.400
<v Speaker 2>unlikely story of the discovery of the HEPB virus, I

0:58:29.440 --> 0:58:33.040
<v Speaker 2>want to quickly mention the Willowbrook State School hepatitis studies,

0:58:33.800 --> 0:58:37.560
<v Speaker 2>which were these unethical experiments that are sometimes referred to

0:58:37.680 --> 0:58:42.440
<v Speaker 2>as the pediatric Tuskegee Oh dear. Yeah. I'm going to

0:58:42.480 --> 0:58:46.080
<v Speaker 2>be brief because these studies are mostly about hepatitis A,

0:58:46.480 --> 0:58:48.960
<v Speaker 2>and so when we do a HEPA episode, I'll go

0:58:49.080 --> 0:58:51.400
<v Speaker 2>into more depth on them. But I wanted to bring

0:58:51.440 --> 0:58:54.040
<v Speaker 2>them up here because these studies mark one of the

0:58:54.080 --> 0:58:57.240
<v Speaker 2>major points in the history of medical ethics and also

0:58:57.280 --> 0:59:01.440
<v Speaker 2>hepatitis B was a part of these studies. So Willowbrook

0:59:01.480 --> 0:59:05.080
<v Speaker 2>State School was a state funded institution established in nineteen

0:59:05.160 --> 0:59:08.800
<v Speaker 2>forty seven on Staten Island, New York, for children who

0:59:08.840 --> 0:59:11.320
<v Speaker 2>were intellectually or developmentally disabled.

0:59:12.120 --> 0:59:13.400
<v Speaker 3>I hate this already, erin.

0:59:13.920 --> 0:59:17.200
<v Speaker 2>I know, I know, I know. In nineteen fifty eight,

0:59:17.320 --> 0:59:21.400
<v Speaker 2>infectious disease physician doctor Saul Krugman from New York University

0:59:21.440 --> 0:59:24.440
<v Speaker 2>in Bellevue Hospital, he was asked to join Willowbrook to

0:59:24.440 --> 0:59:27.280
<v Speaker 2>help figure out why there were such high rates of

0:59:27.320 --> 0:59:30.960
<v Speaker 2>hepatitis among the children there, with something like thirty to

0:59:30.960 --> 0:59:35.160
<v Speaker 2>fifty percent admitted there would end up getting hepatitis, and

0:59:35.400 --> 0:59:37.640
<v Speaker 2>they also asked him to help bring those rates down,

0:59:38.080 --> 0:59:40.560
<v Speaker 2>and so he agreed and set out to not only

0:59:40.600 --> 0:59:44.920
<v Speaker 2>bring down the rates of hepatitis, but also to quote

0:59:45.000 --> 0:59:49.360
<v Speaker 2>describe the circumstances under which the disease occurred and the

0:59:49.400 --> 0:59:53.320
<v Speaker 2>effect of gamma globulin in reducing its occurrence, and an

0:59:53.360 --> 0:59:57.680
<v Speaker 2>attempt to induce passive active immunity by feeding virus to

0:59:57.720 --> 1:00:02.680
<v Speaker 2>persons protected by gamma globulin, and to describe the excretion

1:00:02.800 --> 1:00:06.560
<v Speaker 2>of virus during the incubation period of the disease. Dear,

1:00:07.160 --> 1:00:08.920
<v Speaker 2>your face tells me you've picked up on some of

1:00:08.960 --> 1:00:16.520
<v Speaker 2>the yeah problems with these studies intentionally infecting children. So

1:00:16.640 --> 1:00:20.439
<v Speaker 2>Krugman justified the research by saying that the children would

1:00:20.440 --> 1:00:23.640
<v Speaker 2>inevitably get hepatitis anyway because it was so prevalent in

1:00:23.640 --> 1:00:26.680
<v Speaker 2>the school, and that this way, with his experiments, a

1:00:26.760 --> 1:00:31.680
<v Speaker 2>vaccine could be developed and tested. Parental consent was obtained,

1:00:31.760 --> 1:00:34.160
<v Speaker 2>but it's not clear the extent to which parents were

1:00:34.160 --> 1:00:37.120
<v Speaker 2>told of the risks to their children and what exactly

1:00:37.240 --> 1:00:42.240
<v Speaker 2>was involved. By his own estimation, Krugman's studies reduced the

1:00:42.280 --> 1:00:45.840
<v Speaker 2>incidence of hepatitis by eighty five percent. Again, it's not

1:00:46.680 --> 1:00:50.840
<v Speaker 2>entirely clear which hepatitis, but his study did demonstrate that

1:00:50.880 --> 1:00:54.640
<v Speaker 2>there were two different types of hepatitis transmitted in different ways,

1:00:54.760 --> 1:00:57.200
<v Speaker 2>which like I said, was already kind of known, and

1:00:57.320 --> 1:01:01.280
<v Speaker 2>also tested a prototype of a HEPB vaccine which did

1:01:01.320 --> 1:01:05.720
<v Speaker 2>seem to be somewhat effective. The legacy of the Wiliberg

1:01:05.760 --> 1:01:09.560
<v Speaker 2>hepatitis studies is that the resulting outrage led to very

1:01:09.600 --> 1:01:14.120
<v Speaker 2>strict regulations placed on including children in clinical trials and

1:01:14.240 --> 1:01:17.880
<v Speaker 2>medical studies, and a more revamping of what could be

1:01:17.960 --> 1:01:22.680
<v Speaker 2>considered medical consent. There's a lot more, of course, like

1:01:22.760 --> 1:01:25.200
<v Speaker 2>I said, to these studies and their place in the

1:01:25.240 --> 1:01:28.000
<v Speaker 2>history of medical ethics. And so if you're interested in

1:01:28.080 --> 1:01:30.640
<v Speaker 2>learning more and don't want to wait for our Hepatitis

1:01:30.680 --> 1:01:35.280
<v Speaker 2>A episode, I will list some sources for this on

1:01:35.360 --> 1:01:39.880
<v Speaker 2>our website. And there's also a paper that Krugman wrote

1:01:39.960 --> 1:01:43.440
<v Speaker 2>and published in nineteen eighty six in which he defends

1:01:43.520 --> 1:01:46.880
<v Speaker 2>himself in the research. So that's kind of an interesting read.

1:01:48.080 --> 1:01:50.400
<v Speaker 2>There's like a lot of discussion about this, and I

1:01:50.440 --> 1:01:57.880
<v Speaker 2>didn't do it justice, so let me just say that, Wow, yeah, okay, okay,

1:01:58.120 --> 1:02:03.560
<v Speaker 2>back to strictly hepatitis B. So, by the nineteen sixties,

1:02:03.720 --> 1:02:08.160
<v Speaker 2>the hepatitis B virus had still not been identified, despite

1:02:08.200 --> 1:02:11.720
<v Speaker 2>the fact that tons of people were working on this problem.

1:02:12.360 --> 1:02:15.320
<v Speaker 2>And when it was finally discovered, it wasn't by one

1:02:15.360 --> 1:02:19.080
<v Speaker 2>of those researchers who had dedicated their lives to hepatitis,

1:02:19.920 --> 1:02:23.120
<v Speaker 2>but by a team who had not even been looking

1:02:23.320 --> 1:02:25.640
<v Speaker 2>for hepatitis B or any other virus.

1:02:27.360 --> 1:02:28.360
<v Speaker 3>What were they looking for?

1:02:31.440 --> 1:02:34.280
<v Speaker 2>I feel like this story is such a good example

1:02:34.720 --> 1:02:38.920
<v Speaker 2>of how science like rarely proceeds in an orderly fashion.

1:02:39.040 --> 1:02:44.480
<v Speaker 2>It's not a to B two C it's especially because

1:02:44.560 --> 1:02:47.280
<v Speaker 2>B happens to be the first hepatitis virus discovered.

1:02:47.480 --> 1:02:49.520
<v Speaker 3>Yeah, Okay, I saw that on a timeline and I

1:02:49.560 --> 1:02:51.240
<v Speaker 3>was like, well, well we'll hold on, hold on, hold on.

1:02:51.360 --> 1:02:53.000
<v Speaker 2>I don't know. It was like, why is it called B?

1:02:53.160 --> 1:02:55.360
<v Speaker 3>Then yeah, it doesn't make any sense.

1:02:57.760 --> 1:03:02.880
<v Speaker 2>Yep, everything's just arbitrary. Cool cool, cool yep. But yeah,

1:03:02.920 --> 1:03:06.280
<v Speaker 2>it's like we often tell, like I'm including myself in

1:03:06.320 --> 1:03:11.360
<v Speaker 2>that these stories of scientific discovery in a very linear way,

1:03:11.440 --> 1:03:15.120
<v Speaker 2>in a very like here's this nice little, pretty narrative packaged,

1:03:15.600 --> 1:03:19.480
<v Speaker 2>and that neat narrative does serve a purpose because it

1:03:19.560 --> 1:03:22.120
<v Speaker 2>kind of is like, well, let's find the important things,

1:03:22.200 --> 1:03:26.240
<v Speaker 2>let's find the compelling things. Yeah, but that's not the

1:03:26.280 --> 1:03:30.640
<v Speaker 2>way things happen. It's just simply not. And so this,

1:03:31.160 --> 1:03:34.800
<v Speaker 2>I think really illustrates that sometimes you're looking for one

1:03:34.840 --> 1:03:38.240
<v Speaker 2>thing and you end up stumbling upon something that never

1:03:38.320 --> 1:03:44.320
<v Speaker 2>even crossed your mind. So let's meet doctor Baruch Bloomberg.

1:03:44.520 --> 1:03:45.280
<v Speaker 3>Okay, Hi.

1:03:47.080 --> 1:03:51.000
<v Speaker 2>Since early in his career, Bloomberg became interested in why

1:03:51.120 --> 1:03:55.560
<v Speaker 2>some people get sick and others don't, how genetics interacts

1:03:55.560 --> 1:03:59.360
<v Speaker 2>with human behavior and the environment to lead to disease.

1:03:59.600 --> 1:04:06.120
<v Speaker 2>Basic and he became interested specifically in polymorphisms. So these

1:04:06.120 --> 1:04:09.640
<v Speaker 2>are genetic traits for which there are multiple forms. So

1:04:10.000 --> 1:04:13.080
<v Speaker 2>things like tongue twisting, Can you twist your tongue?

1:04:13.400 --> 1:04:13.720
<v Speaker 3>Yes?

1:04:14.160 --> 1:04:14.680
<v Speaker 2>Can you too?

1:04:15.680 --> 1:04:15.960
<v Speaker 1>Cool?

1:04:16.640 --> 1:04:18.280
<v Speaker 2>Blood types, what blood type are you?

1:04:18.440 --> 1:04:21.960
<v Speaker 3>I'm oh positive, I'm ab positive. I knew that about you.

1:04:22.800 --> 1:04:27.520
<v Speaker 2>I knew that about you. So these are examples of polymorphisms, right, Like,

1:04:27.680 --> 1:04:30.440
<v Speaker 2>there are different forms of these, and there are different

1:04:30.440 --> 1:04:34.920
<v Speaker 2>distributions in human populations, and so he wanted to see

1:04:34.960 --> 1:04:39.000
<v Speaker 2>whether there were any of these polymorphisms that were associated

1:04:39.040 --> 1:04:43.120
<v Speaker 2>with susceptibility to certain diseases. So kind of like asking

1:04:43.160 --> 1:04:46.520
<v Speaker 2>the question, do people with type A blood have a

1:04:46.520 --> 1:04:50.600
<v Speaker 2>greater chance of developing heart disease? And if they do, why,

1:04:51.640 --> 1:04:54.200
<v Speaker 2>But instead of blood types, which at this point had

1:04:54.200 --> 1:04:58.200
<v Speaker 2>already been pretty well established, Bloomberg was interested in finding

1:04:58.440 --> 1:05:03.320
<v Speaker 2>new blood plasma pro teen polymorphisms that could be associated

1:05:03.360 --> 1:05:06.680
<v Speaker 2>with variation in disease susceptibility. So that's what he was

1:05:06.720 --> 1:05:07.240
<v Speaker 2>looking for.

1:05:07.400 --> 1:05:09.320
<v Speaker 3>He wasn't even looking for virus.

1:05:09.680 --> 1:05:12.960
<v Speaker 2>No, he was looking for blood plasma protein polymorphisms.

1:05:13.280 --> 1:05:17.000
<v Speaker 3>Wow, I bet he found some proteins, all right.

1:05:17.280 --> 1:05:24.240
<v Speaker 2>He certainly did, But how did he find these proteins. Yeah, Well,

1:05:24.280 --> 1:05:27.880
<v Speaker 2>he began his search by collecting blood samples from people

1:05:28.000 --> 1:05:30.959
<v Speaker 2>all over the world and then testing them to see

1:05:31.000 --> 1:05:36.360
<v Speaker 2>whether certain antigens appeared and in what frequency. Basically, you

1:05:36.520 --> 1:05:40.040
<v Speaker 2>use the blood of someone who had received multiple transfusions

1:05:40.080 --> 1:05:44.040
<v Speaker 2>to find antibodies against a protein antigen that was new

1:05:44.120 --> 1:05:47.800
<v Speaker 2>to them, and then you test those antibodies against other

1:05:47.840 --> 1:05:52.080
<v Speaker 2>blood samples to see how frequently it reacts, meaning how

1:05:52.080 --> 1:05:57.440
<v Speaker 2>often that protein antigen is present. Yeah, and this might

1:05:57.520 --> 1:06:01.600
<v Speaker 2>seem like a very crude protein today in the days

1:06:01.640 --> 1:06:06.280
<v Speaker 2>of like you know, super inexpensive genomic sequencing, but back then,

1:06:06.600 --> 1:06:09.160
<v Speaker 2>these were the early early years of genetics.

1:06:09.560 --> 1:06:12.080
<v Speaker 3>I mean, we still do that to do like regular

1:06:12.120 --> 1:06:15.760
<v Speaker 3>blood typing. Yeah, so it was like still very useful.

1:06:16.520 --> 1:06:19.840
<v Speaker 2>It so it is, it is super useful. But the approach,

1:06:19.920 --> 1:06:23.400
<v Speaker 2>like the technology that he used, which was Agargell diffusion,

1:06:23.840 --> 1:06:27.240
<v Speaker 2>it was basically like one of the only ones available

1:06:27.240 --> 1:06:31.760
<v Speaker 2>at the time immunology was in its infancy, and so

1:06:31.880 --> 1:06:35.040
<v Speaker 2>with this approach, Bloomberg and his team identified a new

1:06:35.080 --> 1:06:39.320
<v Speaker 2>protein that they called the AG protein AG for antigen.

1:06:40.360 --> 1:06:44.480
<v Speaker 2>This protein, which they found to have an uneven global distribution,

1:06:45.000 --> 1:06:48.440
<v Speaker 2>turned out to be a serum lipoprotein, so serum protein

1:06:48.520 --> 1:06:51.760
<v Speaker 2>combined with fats that may play a role in serum

1:06:51.840 --> 1:06:55.400
<v Speaker 2>cholesterol and triglyceride levels. Maybe not a strong marker for

1:06:55.480 --> 1:06:59.560
<v Speaker 2>disease susceptibility, but it was an encouraging finding. It showed

1:06:59.560 --> 1:07:02.080
<v Speaker 2>that their technique, even though it was, you know, maybe

1:07:02.120 --> 1:07:05.439
<v Speaker 2>a little bit kind of rough handed, could be used

1:07:05.520 --> 1:07:10.760
<v Speaker 2>to find new serum proteins. So they kept looking for

1:07:10.840 --> 1:07:14.160
<v Speaker 2>the next hunt. Bloomberg teamed up with a blood researcher

1:07:14.240 --> 1:07:18.960
<v Speaker 2>named Harvey Alter, whose name you should recognize former hepatitis

1:07:19.040 --> 1:07:22.919
<v Speaker 2>C episode. Except when I looked through my notes for

1:07:23.040 --> 1:07:26.720
<v Speaker 2>his name, I didn't mention that he was the person

1:07:26.720 --> 1:07:33.160
<v Speaker 2>who identified the hepatitis C virus. And I am so embarrassed, Like,

1:07:33.320 --> 1:07:37.720
<v Speaker 2>that's kind of a fundamental, important person for the history

1:07:37.720 --> 1:07:38.400
<v Speaker 2>of hepatitis C.

1:07:39.080 --> 1:07:41.960
<v Speaker 3>I bet you talked about a lot of important things, aren.

1:07:42.280 --> 1:07:46.320
<v Speaker 2>I'm just I'm ashamed, you know, but I am. I'm

1:07:46.360 --> 1:07:50.040
<v Speaker 2>mentioning him here, And I also want to shout out

1:07:50.080 --> 1:07:53.120
<v Speaker 2>that in twenty twenty he was awarded the Nobel Prize

1:07:53.200 --> 1:07:56.600
<v Speaker 2>for his role in hepatitis C research. Ohtty cool?

1:07:56.880 --> 1:07:58.840
<v Speaker 3>Whoa Yeah?

1:07:59.200 --> 1:08:02.600
<v Speaker 2>So anyway, Alter, who was in the beginning of his

1:08:02.960 --> 1:08:06.080
<v Speaker 2>career in the early nineteen sixties, he was interested in

1:08:06.200 --> 1:08:11.400
<v Speaker 2>why some people developed an immune response like a fever, chills, rash, etc.

1:08:12.000 --> 1:08:17.960
<v Speaker 2>After receiving a transfusion. Yeah, interesting, sef And it took

1:08:18.000 --> 1:08:20.000
<v Speaker 2>a little bit of time, little trial and error, but

1:08:20.560 --> 1:08:25.320
<v Speaker 2>alter In Bloomberg found another polymorphism, and this they named

1:08:25.560 --> 1:08:29.120
<v Speaker 2>Australia antigen because it was first found in the blood

1:08:29.160 --> 1:08:34.240
<v Speaker 2>serum of a First Nations person from Australia. And we've

1:08:34.280 --> 1:08:36.840
<v Speaker 2>talked about the problem with place names to describe a

1:08:36.880 --> 1:08:40.880
<v Speaker 2>disease loads of times before. However, I want to point

1:08:40.920 --> 1:08:44.200
<v Speaker 2>out that at the time, this Australia antigen was just

1:08:44.320 --> 1:08:48.120
<v Speaker 2>thought to be a human protein, not necessarily an actual pathogen,

1:08:48.840 --> 1:08:53.040
<v Speaker 2>which surprised spoilers it turned out to be. But in

1:08:53.120 --> 1:08:56.439
<v Speaker 2>any case, the name Australia antigen it didn't stick around

1:08:56.439 --> 1:08:59.360
<v Speaker 2>for very long because it was soon shown that the

1:08:59.360 --> 1:09:03.400
<v Speaker 2>Australia antigen was actually the hepatitis B virus.

1:09:04.280 --> 1:09:05.400
<v Speaker 3>I love this story.

1:09:05.720 --> 1:09:10.280
<v Speaker 2>I know it's I just think it's so amazing. It's like,

1:09:11.040 --> 1:09:13.800
<v Speaker 2>I don't know, it's just such a fun story. So

1:09:13.880 --> 1:09:18.040
<v Speaker 2>how did they make this connection? Well, first, after finding

1:09:18.080 --> 1:09:21.200
<v Speaker 2>this new protein, they decided to look at its geographic

1:09:21.240 --> 1:09:24.120
<v Speaker 2>patterns of prevalence, just like they had for their earlier

1:09:24.320 --> 1:09:27.920
<v Speaker 2>agg protein, which you know, was it more common in

1:09:27.920 --> 1:09:32.280
<v Speaker 2>some areas or in some populations than others, and they

1:09:32.320 --> 1:09:36.320
<v Speaker 2>did find variation in the global distribution. They found that

1:09:36.520 --> 1:09:39.559
<v Speaker 2>the Australia antigen seemed to be somewhat rare in the

1:09:39.680 --> 1:09:42.360
<v Speaker 2>US blood samples that they had, but it was a

1:09:42.360 --> 1:09:45.040
<v Speaker 2>little bit more common in parts of Asia, in the

1:09:45.040 --> 1:09:49.559
<v Speaker 2>Pacific Africa, and eastern and southern Europe. They also showed

1:09:49.560 --> 1:09:53.120
<v Speaker 2>that the antigen seemed to cluster in families, which at

1:09:53.160 --> 1:09:57.920
<v Speaker 2>first glance suggested that it was an inherited tree, but

1:09:58.720 --> 1:10:04.040
<v Speaker 2>as more data came in, that assumption kind of broke down. Yeah,

1:10:04.720 --> 1:10:08.880
<v Speaker 2>uh huh. Bloomberg and his team began getting suspicious that

1:10:08.960 --> 1:10:12.519
<v Speaker 2>it might not be a human protein after all, but

1:10:12.640 --> 1:10:17.160
<v Speaker 2>rather an infectious agent, one that was possibly bloodborn, as

1:10:17.240 --> 1:10:19.800
<v Speaker 2>they had found it in several people who had at

1:10:19.840 --> 1:10:23.880
<v Speaker 2>first tested negative for the antigen but later tested positive

1:10:24.120 --> 1:10:29.360
<v Speaker 2>shortly after receiving a blood transfusion. Oh no. And then

1:10:29.640 --> 1:10:33.120
<v Speaker 2>the connection to hepatitis b fell into place when they

1:10:33.120 --> 1:10:36.040
<v Speaker 2>began to find the antigen at high rates and people

1:10:36.080 --> 1:10:41.920
<v Speaker 2>who had hepatitis okay, especially those with a history of transfusion.

1:10:43.439 --> 1:10:46.640
<v Speaker 2>By nineteen sixty five or so, they had become convinced

1:10:47.000 --> 1:10:50.320
<v Speaker 2>that they had finally found the long sought after hepatitis

1:10:50.360 --> 1:10:54.719
<v Speaker 2>B virus almost by accident, I mean truly by accident, really,

1:10:56.240 --> 1:10:58.840
<v Speaker 2>and they sent off a couple of papers to be published.

1:11:00.040 --> 1:11:05.360
<v Speaker 2>One was outright rejected, with a reviewer commenting that there

1:11:05.400 --> 1:11:09.559
<v Speaker 2>simply wasn't enough evidence in support of their hypothesis. And

1:11:09.720 --> 1:11:12.679
<v Speaker 2>now we look back on this and go, that's absurd.

1:11:13.080 --> 1:11:17.600
<v Speaker 2>How could this monumental finding be rejected? But if you

1:11:17.720 --> 1:11:21.280
<v Speaker 2>consider this in the larger context of the time, it

1:11:21.400 --> 1:11:23.679
<v Speaker 2>does seem like it was kind of like a boy

1:11:23.680 --> 1:11:27.960
<v Speaker 2>who Cried Wolf scenario. People were always submitting articles saying,

1:11:28.080 --> 1:11:30.800
<v Speaker 2>I've found the hepatitis B virus. I have found it.

1:11:30.800 --> 1:11:33.400
<v Speaker 2>It's this, It's this kind of like how I feel

1:11:33.439 --> 1:11:36.400
<v Speaker 2>like every few months nowadays, there's an article saying the

1:11:36.520 --> 1:11:41.120
<v Speaker 2>Zodiac killer has finally been identified. It's like, okay, let's

1:11:41.200 --> 1:11:44.040
<v Speaker 2>if we dig a little deeper, like is it true

1:11:44.160 --> 1:11:48.600
<v Speaker 2>or is it not so close to the truth. But

1:11:48.720 --> 1:11:53.000
<v Speaker 2>another reason for the rejection, and this one is much

1:11:53.040 --> 1:11:56.040
<v Speaker 2>more unfair, is that Bloomberg and his group were in

1:11:56.160 --> 1:11:59.680
<v Speaker 2>no way part of the hepatitis be seen. They had

1:11:59.720 --> 1:12:02.760
<v Speaker 2>no background and studying hepatitis. None of them had been

1:12:02.800 --> 1:12:07.280
<v Speaker 2>trained as epidemiologists, let alone virologists, so what do they

1:12:07.280 --> 1:12:12.720
<v Speaker 2>know about hepatitis? But despite this initial rejection and the

1:12:12.800 --> 1:12:17.280
<v Speaker 2>resentment from some prominent hepatitis researchers, they managed to get

1:12:17.280 --> 1:12:20.960
<v Speaker 2>a paper published in nineteen sixty seven that awakened the

1:12:21.000 --> 1:12:25.640
<v Speaker 2>world to the possibility that the virus causing transfusion hepatitis,

1:12:26.040 --> 1:12:29.000
<v Speaker 2>the hepatitis B virus, had finally been found.

1:12:29.479 --> 1:12:31.320
<v Speaker 3>Nineteen sixty seven.

1:12:32.200 --> 1:12:37.800
<v Speaker 2>Hm. Wow, yeah, and this seems like an understatement, but

1:12:37.880 --> 1:12:42.880
<v Speaker 2>this was huge news at the time. Post transfusion hepatitis

1:12:42.960 --> 1:12:44.559
<v Speaker 2>rates reached thirty percent.

1:12:45.360 --> 1:12:45.760
<v Speaker 3>Oh my.

1:12:47.760 --> 1:12:51.320
<v Speaker 2>The beginnings of the incredible prevalence of global hepatitis that

1:12:51.360 --> 1:12:55.719
<v Speaker 2>we have today really does have its roots during this time.

1:12:56.120 --> 1:12:58.559
<v Speaker 2>During this time when there was a lot of blood

1:12:58.560 --> 1:13:01.640
<v Speaker 2>transfusion happening, a lot of blood products being used, a

1:13:01.640 --> 1:13:06.360
<v Speaker 2>lot of needles being reused, without knowing what the virus was,

1:13:06.439 --> 1:13:09.360
<v Speaker 2>how to test for it, how to prevent it. So

1:13:09.400 --> 1:13:14.599
<v Speaker 2>it's yeah, but there was still another step, and that

1:13:14.640 --> 1:13:19.559
<v Speaker 2>was confirmation from other researchers boom, easily done. Check, here's

1:13:19.560 --> 1:13:28.200
<v Speaker 2>hepatitis be the end, almost the end actually, the discovery

1:13:28.320 --> 1:13:32.640
<v Speaker 2>of the hepatitis B virus. This allowed not only for

1:13:32.720 --> 1:13:35.960
<v Speaker 2>the testing of hepatitis B virus and blood products, but

1:13:36.040 --> 1:13:39.280
<v Speaker 2>also the identification of carriers of the virus and the

1:13:39.320 --> 1:13:43.760
<v Speaker 2>eventual development of a vaccine. This isn't to say that

1:13:43.840 --> 1:13:47.360
<v Speaker 2>it was all smooth sailing. After the link between the

1:13:47.400 --> 1:13:51.959
<v Speaker 2>Australia antigen and the hepatitis B virus was made. For instance,

1:13:52.040 --> 1:13:54.920
<v Speaker 2>the virus was still not able to be maintained in

1:13:55.040 --> 1:14:00.479
<v Speaker 2>conventional tissue cultures, which made fulfilling Cook's postulis difficult, and

1:14:00.720 --> 1:14:03.120
<v Speaker 2>the test for determining whether or not the virus was

1:14:03.200 --> 1:14:08.120
<v Speaker 2>present pretty insensitive at the time. Like I've seen estimates

1:14:08.120 --> 1:14:11.240
<v Speaker 2>of fifteen to twenty percent of the time it would

1:14:11.280 --> 1:14:15.400
<v Speaker 2>detect hepatitis B virus. Yeah, that's pretty bad. It's gotten

1:14:15.400 --> 1:14:18.719
<v Speaker 2>a lot better. We should point out a lot lot better,

1:14:19.080 --> 1:14:25.479
<v Speaker 2>like very good, like excellent. And as I always talk about,

1:14:25.560 --> 1:14:29.599
<v Speaker 2>there's typically this delay from when something new is discovered

1:14:29.640 --> 1:14:32.599
<v Speaker 2>to when there is wide enough acceptance for that knowledge

1:14:32.600 --> 1:14:37.360
<v Speaker 2>to be applied, especially in like a medical setting. So

1:14:37.479 --> 1:14:41.040
<v Speaker 2>screening the blood supply for hepatitis B. Even with this,

1:14:41.439 --> 1:14:44.840
<v Speaker 2>you know, pretty poor test didn't start for a few

1:14:44.920 --> 1:14:48.879
<v Speaker 2>years after the virus was discovered, So in nineteen seventy

1:14:48.920 --> 1:14:52.519
<v Speaker 2>the hepatitis B virus tests became official in the US,

1:14:52.840 --> 1:14:56.000
<v Speaker 2>and in nineteen seventy two the American Association of Blood

1:14:56.040 --> 1:15:00.280
<v Speaker 2>Banks had begun to require the testing of donors, though

1:15:00.320 --> 1:15:04.120
<v Speaker 2>the test desperately needed to be improved. That was a

1:15:04.120 --> 1:15:07.519
<v Speaker 2>good start, but being able to test for hepatitis B

1:15:07.680 --> 1:15:11.320
<v Speaker 2>virus also meant that it could identify people who were

1:15:11.360 --> 1:15:15.240
<v Speaker 2>carriers or infected with hepatitis B, which then led to

1:15:15.560 --> 1:15:21.240
<v Speaker 2>widespread discrimination and ostracization for people who were positive for

1:15:21.280 --> 1:15:24.720
<v Speaker 2>appatitis B. People were fired from jobs, they were not

1:15:24.800 --> 1:15:29.120
<v Speaker 2>allowed in classrooms, children were taken off adoption lists. People

1:15:29.160 --> 1:15:33.000
<v Speaker 2>were being denied healthcare from shared machines like dialysis machines.

1:15:33.240 --> 1:15:36.400
<v Speaker 2>They were being denied admittance to medical school or kicked

1:15:36.439 --> 1:15:39.479
<v Speaker 2>out of their jobs as doctors or dentists. I mean,

1:15:39.479 --> 1:15:42.920
<v Speaker 2>the list goes on and on. It was just like, oh, great,

1:15:42.920 --> 1:15:45.720
<v Speaker 2>we have this test, we can help prevent hepatitis and

1:15:45.920 --> 1:15:50.240
<v Speaker 2>also we can put the scarlet letter of hepatitis on

1:15:50.320 --> 1:15:51.759
<v Speaker 2>every single person that we test.

1:15:52.840 --> 1:15:57.200
<v Speaker 3>I feel like that part of hepatitis B especially is

1:15:57.320 --> 1:16:04.960
<v Speaker 3>so overlooked today, hmm, Like yeah, yeah.

1:16:03.960 --> 1:16:06.920
<v Speaker 2>And yeah, a lot of these, many or most of

1:16:06.960 --> 1:16:11.759
<v Speaker 2>these restrictions or regulations have been overturned, but the stigma

1:16:11.840 --> 1:16:15.800
<v Speaker 2>and isolation faced by many people with hepatitis B continues

1:16:15.840 --> 1:16:20.160
<v Speaker 2>today and has a huge detrimental impact on their quality

1:16:20.160 --> 1:16:24.800
<v Speaker 2>of life. Right after the hepatitis B virus was identified,

1:16:25.080 --> 1:16:28.959
<v Speaker 2>many people began working on a hepatitis B vaccine, including

1:16:29.000 --> 1:16:32.559
<v Speaker 2>Bloomberg and his colleague doctor Irving Millman, who came out

1:16:32.600 --> 1:16:35.719
<v Speaker 2>with one in nineteen sixty nine, and over the next

1:16:35.760 --> 1:16:39.040
<v Speaker 2>decade people would work on refining the vaccine and incorporating

1:16:39.080 --> 1:16:42.479
<v Speaker 2>it into routine vaccine schedules. And I think since then

1:16:42.479 --> 1:16:45.519
<v Speaker 2>it's kind of faced like continuous like tweaking, and we've

1:16:45.560 --> 1:16:49.760
<v Speaker 2>gotten a pretty solid, from my understanding, hepatitis B vaccine.

1:16:50.400 --> 1:16:50.639
<v Speaker 1>Yeah.

1:16:50.640 --> 1:16:54.240
<v Speaker 3>Since nineteen eighty one was when the hepatitis BA vaccine

1:16:54.280 --> 1:16:58.559
<v Speaker 3>was licensed like in the US widespread by the FDA,

1:16:58.680 --> 1:17:01.559
<v Speaker 3>and then nineteen eighty six it was updated to not

1:17:01.680 --> 1:17:08.320
<v Speaker 3>have any like human parts in it. Essentially it's made

1:17:08.360 --> 1:17:11.759
<v Speaker 3>in a yeast and it's a real combinant vaccine, and

1:17:11.800 --> 1:17:13.720
<v Speaker 3>as far as I know, it's the same vaccine since

1:17:13.800 --> 1:17:14.679
<v Speaker 3>nineteen eighty six.

1:17:15.240 --> 1:17:18.719
<v Speaker 2>Do you know who helped work on the yeast aspect

1:17:18.760 --> 1:17:19.120
<v Speaker 2>of it?

1:17:19.160 --> 1:17:20.200
<v Speaker 3>Tell me who erin?

1:17:21.520 --> 1:17:24.920
<v Speaker 2>Maurice Hillman are Oh, let's hear it for Maurice. He's

1:17:24.920 --> 1:17:29.400
<v Speaker 2>here for Maurice. And I already mentioned one person in

1:17:29.400 --> 1:17:32.360
<v Speaker 2>this story who was the recipient of a Nobel Prize

1:17:32.400 --> 1:17:35.960
<v Speaker 2>for their work on hepatitis viruses, and that was in

1:17:36.000 --> 1:17:40.120
<v Speaker 2>twenty twenty. But in nineteen seventy six, doctor Brooke Bloomberg

1:17:40.479 --> 1:17:44.200
<v Speaker 2>was awarded the Nobel Prize in Physiology or Medicine for

1:17:44.240 --> 1:17:46.800
<v Speaker 2>his work and identifying the hepatitis B virus.

1:17:47.240 --> 1:17:47.639
<v Speaker 3>Love it.

1:17:48.600 --> 1:17:51.920
<v Speaker 2>Also that same year it was co awarded to two

1:17:51.960 --> 1:17:54.599
<v Speaker 2>different people, just to you know that didn't have any

1:17:54.960 --> 1:18:00.160
<v Speaker 2>work together. The other person awarded was Carlton Gadgasek. You

1:18:00.160 --> 1:18:04.639
<v Speaker 2>remember him from Preon's The Bad Guy. Yes, yes, I do.

1:18:05.600 --> 1:18:08.760
<v Speaker 3>Uh huh.

1:18:08.920 --> 1:18:13.240
<v Speaker 2>Over the decades since the discovery of the hepatitis B virus,

1:18:13.760 --> 1:18:18.280
<v Speaker 2>there's been a great deal of research on understanding transmission dynamics,

1:18:18.439 --> 1:18:23.120
<v Speaker 2>genotype differences, the cancer causing potential of the hepatitis B virus.

1:18:23.560 --> 1:18:28.600
<v Speaker 2>New hepatitis viruses like hepatitis D, like hepatitis C, like

1:18:28.640 --> 1:18:34.120
<v Speaker 2>hepatitis E, better blood tests, improved vaccines, harm reduction programs,

1:18:34.400 --> 1:18:38.160
<v Speaker 2>and a growing recognition of the tremendous global burden that

1:18:38.240 --> 1:18:42.000
<v Speaker 2>this virus has in a physical, economic, and emotional sense.

1:18:43.120 --> 1:18:46.160
<v Speaker 2>And despite all of the advancements made in the field

1:18:46.200 --> 1:18:51.559
<v Speaker 2>of hepatitis B research, the virus is still extraordinarily prevalent

1:18:52.200 --> 1:18:59.439
<v Speaker 2>and transmission continues today. So, Aaron, that was kind of

1:18:59.520 --> 1:19:04.120
<v Speaker 2>a quick wrap up to the future. But I want

1:19:04.160 --> 1:19:07.680
<v Speaker 2>to hear where we stand with hepatitis B today. So

1:19:08.120 --> 1:19:08.880
<v Speaker 2>can you fill me in?

1:19:09.360 --> 1:19:45.160
<v Speaker 3>Oh, I can't wait to right after this break. Unlike

1:19:45.200 --> 1:19:50.720
<v Speaker 3>our first three episodes, I have some a lot of

1:19:50.760 --> 1:19:55.920
<v Speaker 3>statistics for this section, Aaron, first three episodes of this season,

1:19:55.960 --> 1:20:02.559
<v Speaker 3>I mean, but they're pretty sobering. Okay. Globally, it is

1:20:02.680 --> 1:20:09.000
<v Speaker 3>estimated that close to four percent of the entire world's

1:20:09.240 --> 1:20:16.640
<v Speaker 3>population is living with chronic hepatitis B infection. That is

1:20:16.760 --> 1:20:24.280
<v Speaker 3>close to three hundred million human beings. And believe it

1:20:24.360 --> 1:20:27.320
<v Speaker 3>or not, that's an improvement because the very first paper

1:20:27.360 --> 1:20:29.759
<v Speaker 3>I read was a bit older, from two thousand and four,

1:20:29.960 --> 1:20:33.280
<v Speaker 3>and that started off by saying over four hundred million people,

1:20:33.960 --> 1:20:35.679
<v Speaker 3>So we're down.

1:20:36.000 --> 1:20:38.880
<v Speaker 2>So those are people chronically infected.

1:20:38.920 --> 1:20:41.599
<v Speaker 3>Right, living with chronic hepatitis being and how.

1:20:41.520 --> 1:20:44.400
<v Speaker 2>Many people are infected newly every year?

1:20:44.520 --> 1:20:48.920
<v Speaker 3>What's the The World Health Organization estimates one point five

1:20:49.160 --> 1:20:52.559
<v Speaker 3>million people are newly infected every year.

1:20:52.800 --> 1:20:53.400
<v Speaker 2>Wow.

1:20:54.400 --> 1:21:01.240
<v Speaker 3>Yes, it's horrific. If we look at the entire spectrum

1:21:01.439 --> 1:21:05.880
<v Speaker 3>or the whole alphabet of hepatida or viral hepatitis is

1:21:07.600 --> 1:21:13.680
<v Speaker 3>viral hepatitis caused an estimated one point three four million

1:21:13.880 --> 1:21:18.920
<v Speaker 3>deaths in twenty fifteen alone, which is more than HIV.

1:21:20.160 --> 1:21:24.120
<v Speaker 3>It is substantially more than malaria, and it's nearly as

1:21:24.240 --> 1:21:25.840
<v Speaker 3>much as tuberculosis.

1:21:26.280 --> 1:21:29.360
<v Speaker 2>So why does it feel like it's not talked about?

1:21:30.160 --> 1:21:30.400
<v Speaker 1>Why?

1:21:30.680 --> 1:21:34.400
<v Speaker 3>Erin, I don't know, Okay, And that's all of the

1:21:34.479 --> 1:21:41.160
<v Speaker 3>viral hepatitis hepatidi Okay. Of all of those deaths, ninety

1:21:41.240 --> 1:21:45.880
<v Speaker 3>six percent are estimated to be from chronic hepatitis. And

1:21:46.160 --> 1:21:49.960
<v Speaker 3>of that ninety six percent, sixty six percent of those

1:21:50.040 --> 1:21:53.960
<v Speaker 3>are from hepatitis B. So if we do some aerin math,

1:21:54.479 --> 1:21:57.280
<v Speaker 3>just kidding, just kidding, the World Health Organization did this

1:21:57.400 --> 1:22:04.280
<v Speaker 3>that that is eight hundred and twenty thousand humans that

1:22:04.320 --> 1:22:09.200
<v Speaker 3>are dying from chronic hepatitis B infection every single year.

1:22:12.560 --> 1:22:13.800
<v Speaker 2>Ah.

1:22:14.640 --> 1:22:18.120
<v Speaker 3>Now you asked why we're not talking about it. Yeah,

1:22:18.120 --> 1:22:21.040
<v Speaker 3>here's probably a large part of it. That burden is

1:22:21.200 --> 1:22:25.040
<v Speaker 3>not born equally across the globe, of course not. The

1:22:25.080 --> 1:22:30.040
<v Speaker 3>World Health Organization, you know, divides the globe into different regions.

1:22:30.920 --> 1:22:35.040
<v Speaker 3>The Western Pacific region by far has the highest incidents

1:22:35.040 --> 1:22:38.439
<v Speaker 3>and prevalence of hepatitis BE, followed by the World Health

1:22:38.520 --> 1:22:42.599
<v Speaker 3>Organization African region. And in these areas the prevalence can

1:22:42.640 --> 1:22:47.479
<v Speaker 3>be as high as six percent or greater in some cases, wow, oh,

1:22:48.120 --> 1:22:50.759
<v Speaker 3>whereas in some parts of the world, like in Europe

1:22:50.880 --> 1:22:53.120
<v Speaker 3>or in North America, the prevalence may be less than

1:22:53.160 --> 1:22:58.720
<v Speaker 3>one percent. And so I think that huge global discrepancy

1:22:59.240 --> 1:23:03.160
<v Speaker 3>can lead for some countries to not think a lot

1:23:03.280 --> 1:23:05.000
<v Speaker 3>or talk a lot about hepatitis B.

1:23:05.400 --> 1:23:08.320
<v Speaker 2>Yeah, it's oh, well, it's not a problem here, so.

1:23:10.280 --> 1:23:17.599
<v Speaker 3>Exactly, Aaron, I think I wrote those exact words later on. Yeah,

1:23:17.800 --> 1:23:21.800
<v Speaker 3>And it gets more sobering because it's also estimated that

1:23:21.880 --> 1:23:26.880
<v Speaker 3>only ten percent ten and a half percent of people

1:23:26.920 --> 1:23:32.280
<v Speaker 3>that are living with hepatitis B know their status. And

1:23:32.360 --> 1:23:35.479
<v Speaker 3>it's also estimated that only twenty two percent of those

1:23:35.920 --> 1:23:39.400
<v Speaker 3>that are diagnosed that know their status are on treatment

1:23:39.479 --> 1:23:42.800
<v Speaker 3>for chronic hepatitis. Be that statistic I want you to

1:23:42.880 --> 1:23:46.360
<v Speaker 3>take with a grain of salt, because not everyone who

1:23:46.400 --> 1:23:50.000
<v Speaker 3>is diagnosed with chronic hepatitis B necessarily needs treatment, at

1:23:50.080 --> 1:23:53.639
<v Speaker 3>least not right away, So that statistic at least might

1:23:53.680 --> 1:23:56.840
<v Speaker 3>not be quite as bad as it sounds. But ten

1:23:56.920 --> 1:24:00.280
<v Speaker 3>percent of people knowing their status is pretty bad.

1:24:00.920 --> 1:24:04.000
<v Speaker 2>Yeah, that's I mean, that's yeah.

1:24:04.800 --> 1:24:10.439
<v Speaker 3>Yeah, it's also I have more numbers as a number

1:24:10.479 --> 1:24:15.839
<v Speaker 3>heavy one, and these numbers are from a modeling study

1:24:15.880 --> 1:24:21.360
<v Speaker 3>from twenty sixteen data. But of this almost four percent

1:24:21.439 --> 1:24:24.840
<v Speaker 3>of the global population that is infected with chronic hepatitis B,

1:24:26.080 --> 1:24:29.160
<v Speaker 3>between one point six to two point two million are

1:24:29.240 --> 1:24:33.800
<v Speaker 3>children under the age of five, and the World Health

1:24:33.880 --> 1:24:38.000
<v Speaker 3>Organization most recent data does suggest that it's now finally

1:24:38.560 --> 1:24:42.800
<v Speaker 3>just under one percent of all children worldwide under age

1:24:42.800 --> 1:24:46.400
<v Speaker 3>five that are chronically infected. That's down from around five

1:24:46.520 --> 1:24:50.200
<v Speaker 3>percent of all children in the pre vaccine era. Oh

1:24:50.240 --> 1:24:55.559
<v Speaker 3>my gosh, I know, and still like just under one percent,

1:24:55.800 --> 1:25:00.840
<v Speaker 3>essentially one percent of all kids under age five globally

1:25:01.400 --> 1:25:06.120
<v Speaker 3>living with this chronic infection. That I can't emphasize enough

1:25:06.760 --> 1:25:12.280
<v Speaker 3>is entirely preventable. At this point, we have had a

1:25:12.400 --> 1:25:16.439
<v Speaker 3>vaccine for hepatitis B that is ninety eight to one

1:25:16.520 --> 1:25:23.320
<v Speaker 3>hundred percent effective for seventeen to thirty years, like not

1:25:23.520 --> 1:25:29.520
<v Speaker 3>a lot of waning immunity, incredibly effective vaccine for forty years.

1:25:29.920 --> 1:25:33.280
<v Speaker 2>So I have a question about that. So is it

1:25:33.400 --> 1:25:37.080
<v Speaker 2>part of every single routine vaccine schedule.

1:25:37.560 --> 1:25:41.160
<v Speaker 3>Over one hundred and eighty countries have hepatitis B as

1:25:41.200 --> 1:25:45.320
<v Speaker 3>part of their universal vaccine program, and it's estimated that

1:25:45.479 --> 1:25:50.679
<v Speaker 3>eighty seven percent of infants worldwide received the three dose

1:25:51.560 --> 1:25:54.960
<v Speaker 3>B vaccine series in their first year of life, which

1:25:55.000 --> 1:25:59.800
<v Speaker 3>is great, but only forty six percent likely had a

1:25:59.840 --> 1:26:06.360
<v Speaker 3>timely birth vaccination that critical twelve to twenty four hour window,

1:26:06.880 --> 1:26:11.320
<v Speaker 3>and even less, this study estimated about thirteen percent got

1:26:11.479 --> 1:26:15.920
<v Speaker 3>both the hepatitis B vaccine and if needed, that IVIG

1:26:16.120 --> 1:26:21.720
<v Speaker 3>to actually treat and provide more passive immunity. But with

1:26:22.040 --> 1:26:26.639
<v Speaker 3>IVIG and the vaccine within twelve to twenty four hours

1:26:26.680 --> 1:26:30.080
<v Speaker 3>of birth, it's still about ninety one percent effective to

1:26:30.240 --> 1:26:35.400
<v Speaker 3>prevent B infection in those babies. But it's even more

1:26:35.520 --> 1:26:39.000
<v Speaker 3>effective if you can treat the pregnant person to lower

1:26:39.040 --> 1:26:43.240
<v Speaker 3>their viral load okay, And it's estimated that only about

1:26:43.280 --> 1:26:46.799
<v Speaker 3>one percent of pregnant people are actually getting that testing

1:26:46.840 --> 1:26:52.760
<v Speaker 3>and then treatment one percent. Yeah, one percent or less,

1:26:54.120 --> 1:26:58.320
<v Speaker 3>And so that contributes a lot to the overall burden

1:26:58.360 --> 1:27:00.800
<v Speaker 3>and why we still have such high infection rates.

1:27:02.160 --> 1:27:04.000
<v Speaker 2>We have the tools, just not the delivery.

1:27:04.560 --> 1:27:08.400
<v Speaker 3>Yeah, so we have a lot of improvements to still

1:27:08.560 --> 1:27:09.520
<v Speaker 3>be made.

1:27:09.760 --> 1:27:10.680
<v Speaker 2>Yeah.

1:27:10.720 --> 1:27:18.320
<v Speaker 3>Overall, this is a massive, massive disease. I honestly didn't

1:27:18.320 --> 1:27:21.480
<v Speaker 3>even realize how massive it was before researching for this episode.

1:27:21.960 --> 1:27:25.759
<v Speaker 3>And because it's such an enormous global problem, I'm glad

1:27:25.800 --> 1:27:28.200
<v Speaker 3>that we were able to highlight so many different parts

1:27:28.200 --> 1:27:32.200
<v Speaker 3>of this really important disease. But there are still several

1:27:32.200 --> 1:27:35.800
<v Speaker 3>aspects that we didn't fully cover in this episode, especially

1:27:36.000 --> 1:27:39.840
<v Speaker 3>the substantial stigma and discrimination faced by so many people

1:27:39.880 --> 1:27:41.799
<v Speaker 3>living with hepatitis BE around the world.

1:27:42.280 --> 1:27:45.840
<v Speaker 2>Right, And because this is such an important part of

1:27:45.880 --> 1:27:49.400
<v Speaker 2>the hepatitis B story, I am so excited to be

1:27:49.439 --> 1:27:51.760
<v Speaker 2>able to take a deeper dive into it in a

1:27:51.800 --> 1:27:54.400
<v Speaker 2>bonus episode coming out next week.

1:27:54.439 --> 1:27:58.120
<v Speaker 3>Woo oooh, you heard that right, bonus episode.

1:27:58.640 --> 1:28:02.160
<v Speaker 2>So I enlisted the help of the amazing doctor Sherry Cohen,

1:28:02.200 --> 1:28:05.240
<v Speaker 2>who is senior vice president of the Hepatitis B Foundation

1:28:05.880 --> 1:28:08.800
<v Speaker 2>to discuss some of the drivers of stigma and discrimination

1:28:08.920 --> 1:28:12.320
<v Speaker 2>in hepatitis B and what's being done about it. I

1:28:12.360 --> 1:28:15.400
<v Speaker 2>also got to pick doctor Cohen's brain about what it's

1:28:15.479 --> 1:28:18.720
<v Speaker 2>like to work in the public health nonprofit world, what

1:28:18.760 --> 1:28:21.920
<v Speaker 2>the differences between a doctor of public health and a

1:28:21.920 --> 1:28:26.240
<v Speaker 2>PhD is, and some fantastic advice for people who might

1:28:26.280 --> 1:28:28.960
<v Speaker 2>be interested in pursuing a career in public health.

1:28:29.200 --> 1:28:31.040
<v Speaker 3>And we know there's a lot of you out there.

1:28:31.160 --> 1:28:33.760
<v Speaker 2>There's a lot of you out there. Yes, it was

1:28:33.840 --> 1:28:36.719
<v Speaker 2>so much fun chatting with doctor Cohen, and you should

1:28:36.760 --> 1:28:39.880
<v Speaker 2>definitely mark your calendars so you don't miss the app.

1:28:40.240 --> 1:28:44.679
<v Speaker 2>It comes out next Tuesday, February first. Okay, but should

1:28:44.720 --> 1:28:47.200
<v Speaker 2>we maybe wrap up this episode for now?

1:28:47.400 --> 1:28:49.960
<v Speaker 3>I think we should time for sources.

1:28:50.439 --> 1:28:55.160
<v Speaker 2>It is a right. So I have a lot of

1:28:55.160 --> 1:28:59.200
<v Speaker 2>papers for this, and I'll post them all on our website,

1:28:59.240 --> 1:29:01.360
<v Speaker 2>but I do want to shout that one book in particular,

1:29:01.439 --> 1:29:03.960
<v Speaker 2>and that is, of course, Hepatitis B The Hunt for

1:29:04.000 --> 1:29:06.880
<v Speaker 2>a Killer Virus by doctor Bruke Blumberg.

1:29:07.640 --> 1:29:10.880
<v Speaker 3>I have a few papers, not as many for this

1:29:11.000 --> 1:29:14.560
<v Speaker 3>as some episodes, but a few really nice review papers.

1:29:15.240 --> 1:29:17.280
<v Speaker 3>Most of them are from the Lancet and they've just

1:29:17.320 --> 1:29:20.080
<v Speaker 3>been like updates on each other. So the most recent

1:29:20.080 --> 1:29:22.200
<v Speaker 3>one that I read was published in twenty eighteen and

1:29:22.240 --> 1:29:25.639
<v Speaker 3>called Chronic Hepatitis B Virus Infection has a lot more

1:29:25.680 --> 1:29:29.240
<v Speaker 3>detail about the different phases of chronic infection, and we'll

1:29:29.280 --> 1:29:32.400
<v Speaker 3>post the sources for this episode and every one of

1:29:32.400 --> 1:29:34.960
<v Speaker 3>our episodes on our website. This podcast will kill you

1:29:34.960 --> 1:29:35.479
<v Speaker 3>dot com.

1:29:35.920 --> 1:29:40.320
<v Speaker 2>We sure will. A big thank you again to doctor

1:29:40.360 --> 1:29:43.160
<v Speaker 2>Wong for taking the time to chat with us and

1:29:43.520 --> 1:29:46.800
<v Speaker 2>being willing to share your experiences with hepatitis B. And

1:29:46.880 --> 1:29:48.720
<v Speaker 2>also thanks for all the awesome work you do.

1:29:49.360 --> 1:29:53.240
<v Speaker 3>Yeah, thank you so much. Thank you also to Bloodmobile

1:29:53.320 --> 1:29:55.519
<v Speaker 3>for providing the music for this episode and all of

1:29:55.520 --> 1:29:56.800
<v Speaker 3>our episodes.

1:29:56.479 --> 1:29:58.880
<v Speaker 2>And thank you too, exactly right of whom we are

1:29:58.960 --> 1:30:00.360
<v Speaker 2>a very proud member.

1:30:01.120 --> 1:30:04.960
<v Speaker 3>And thank you of course to you listeners. We love

1:30:05.040 --> 1:30:07.640
<v Speaker 3>making this podcast and we couldn't do it if you

1:30:07.640 --> 1:30:09.360
<v Speaker 3>didn't listen to it.

1:30:09.320 --> 1:30:13.080
<v Speaker 2>That's very true. And also an extra big thank you

1:30:13.439 --> 1:30:17.360
<v Speaker 2>as always to our wonderful patrons. We love you. You're amazing,

1:30:17.640 --> 1:30:21.960
<v Speaker 2>We love it. Okay, Well, until next time, wash your

1:30:21.960 --> 1:30:22.400
<v Speaker 2>hands

1:30:22.640 --> 1:30:23.800
<v Speaker 3>You filthy animals.